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Abstract 
A Fluorescence Investigation of Laterally Phase Separated Cholesterol Rich 
Domains in Model Lipid Membranes Using the Membrane Probe 
1-myristoyl-2-[12-[(5-dimethylamino-1-naphthalenesulfonyl)amino]dodecanoyl]-
sn-Glycero-3-phosphocholine 
Gregory M. Troup 
Steven P. Wrenn, Ph.D. 
 
 
 
 
This work utilizes the fluorescence properties of the membrane probes 1-
acyl-2-[12-[(5-dimethylamino-1-naphthalenesulfonyl)amino]dodecanoyl]-sn-
Glycero-3-phosphocholine (DANSYL), and ergosta-5,7,9(11),22-tetraen-3β-ol 
(ERGO) to detect and characterize laterally phase-separated, cholesterol-rich 
domains in 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)/cholesterol, 
and egg lecithin(Egg-PC)/cholesterol model membrane systems.  Specifically, the 
DANSYL membrane probe shows evidence of lateral phase separations in 
DMPC/Cholesterol and Egg-PC/Cholesterol membrane mixtures and can reveal 
liquid-ordered to liquid-disordered phase boundaries.  Fluorescence resonance 
energy transfer from ERGO to DANSYL is used to characterize the size of the 
putative laterally phase separated cholesterol-rich domains in model membrane 
systems.  The DANSYL red shifting data provides evidence for the presence of a 
lateral phase separation in the cholesterol regime that was thought to be only in 
the liquid ordered phase.  Simulations were conducted using two vertically-
coupled square two-dimensional lattices to simulate membrane bilayers 
containing a uniform size distribution of cholesterol immiscible domains of a 
predetermined size distribution.  We substitute cholesterols and phospholipids 
with their fluorescent analogs and calculate the efficiency of energy transfer as a 
 xiii
function of acceptor concentration for four membrane configurations.  We show 
that the FRET model yields good size estimates for domains that range between 1 
and 25 nm.  We also find that the assumed fluorophore configuration in the FRET 
model leads to a constant under-prediction of these values.  Finally, we 
demonstrate that when two parameters are open to the fit, the FRET model 
adequately predicts the donor partition coefficient in addition to the domain size.  
Finally, we present a steady-state and time-resolved fluorescence emission spectra 
analysis of the membrane probe 1-myristoyl-2-[12-[(5-dimethylamino-1-
naphthalenesulfonyl)amino]dodecanoyl]-sn-Glycero-3-phosphocholine 
(DANSYL) in 1,2-dimyristoyl-sn-glycero-3-phosphocholine and cholesterol 
multi-lamellar vesicles prepared by modified rapid solvent exchange.  We report 
that the dose-dependent cholesterol-induced blue shifts in the steady-state 
fluorescence emission spectra in 1,2-dimyristoyl-sn-glycero-3-phosphocholine 
multi-lamellar vesicles are due to complex solvent effects that include time-
dependent dipolar relaxation, and the formation of internal charge transfer states.  
A key finding of this study is identification of two distinguishable DANSYL 
populations existing at both shallow and deep locations in membrane, these two 
DANSYL populations are evidence of the presence of laterally phase separated 
domains.  
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CHAPTER 1: Introduction 
 
Cholesterol is a necessary component in the cellular membranes of 
mammals, but it is also related to deadly diseases that plague mankind such as 
gallstone disease and heart disease.  This dual role of cholesterol has lead to 
numerous studies involving cholesterol and its effects.  In particular the effect of 
cholesterol on the properties of biological membranes has been an area of intense 
investigation, and despite over fifty years of research a clear picture has still not 
emerged [1].  Of recent interest is the role that cholesterol plays on membrane 
phase behavior, specifically in the formation of discrete laterally phase-separated 
functional domains termed rafts.  Rafts are hypothesized to play important roles in 
lipid and protein sorting.  Experimental evidence for these proposed rafts suggest 
that they are enriched in cholesterol [2].  Another raft type structure has been 
recently reported to exist in natural membranes termed immiscible cholesterol 
domains [3].  Immiscible cholesterol domains are a tail-to-tail cholesterol-only 
phase existing in the membrane.  These cholesterol–rich, and pure cholesterol 
laterally phase separated domains may be important in the nucleation mechanism 
of cholesterol from phospholipid membranes, which is presently not well 
understood, but the finding of pure cholesterol domains suggests that the 
nucleation pathway includes lateral phase separation.  Pure cholesterol domains 
have also been identified in ocular lens fiber cells and shown to be important for 
maintaining lens transparency [4].  Again, these findings show how cholesterol 
can be both helpful and harmful to humans.  An understanding of cholesterol 
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induced laterally phase separated domains in model membrane systems will be 
valuable in understanding the role that such similar domains such as rafts may 
play in natural membranes and lead to an improved understanding of cholesterol 
related diseases as well as normal cell function.   
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CHAPTER 2: Background 
 
2.1 Lipid phases in single component phospholipid bilayers 
Single component phospholipid bilayer membranes at high water content 
can exist in three phases: the gel phase, the ripple phase, and the liquid crystalline 
phase, depending on temperature.  The gel and liquid crystalline phases are 
characterized by the configurations of the phospholipid acyl chains.  A rippled 
appearance at the bilayer surface characterizes the ripple phase.  A discussion of 
the characteristics of the single component lipid phases is given in following 
subsections.   
2.1.1 Gel Phase 
In the gel phase the phospholipid acyl chains are in the all trans 
configuration as opposed to the gauche configuration [1].  The all trans 
configuration allows the phospholipid acyl chains to be maximally extended.  The 
maximum extension of the acyl chains allows lipid molecules to tightly pack.  The 
tight packing of the acyl chains gives this phase its gel like nature.  This phase is 
also characterized by an increased bilayer thickness compared to the liquid 
crystalline phase.   
2.1.2 Liquid Crystalline Phase 
The liquid crystalline phase is what is thought to be the phase of most of 
the lipids in natural membranes [1].  The phospholipid acyl chains in the liquid 
crystalline phase contain mostly gauche configurations [1].  The gauche 
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configurations give this phase a high degree of disorder in the acyl chain region of 
the bilayer.  The acyl chain disorder gives this phase its fluid like nature.   
2.1.3 Ripple Phase 
Electron micrograph studies show a bilayer phase that has a “rippled” 
surface, which is termed the ripple phase [1].  The ripple phase occurs between 
the gel and liquid crystalline phase in temperature.  Raman scattering data show 
that in DPPC membrane ripple phases the acyl chains are mostly in the all trans 
configuration [2].   
2.2 Lipid phases in cholesterol-phospholipid bilayers 
The presence of cholesterol alters the above phases somewhat, thus a 
different terminology exists for lipid phases present in phospholipid-cholesterol 
mixtures.  A phase with similar properties to the gel phase in cholesterol-
phospholipid membranes is termed the solid ordered phase (so), and a phase with 
similar properties to the liquid crystalline phase is termed the liquid disordered 
phase (ld).  In cholesterol-phospholipid membranes a new lipid phase emerges 
called the liquid ordered phase (lo).  The lo phase is rich in cholesterol, resulting in 
the phospholipid acyl chains being extended and tightly packed.  However, the lo 
phase has a high degree of lateral mobility.  Model membrane systems comprised 
of phospholipids and cholesterol have been shown to exhibit regions of two-phase 
co-existence, where the ld phase is in equilibrium with the lo phase [3].  In these 
model systems, the phase separation is not an infinite bulk macroscopic phase 
separation.  Rather the ld/ lo phase equilibrium is a discrete or dispersed phase 
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within a continuous phase.  Both the lo phase and the ld phase can be the dispersed 
phase depending on the relative amounts of each phase. 
2.2.1 Cholesterol in phospholipid bilayers 
In addition to lipids, animal cell membranes also contain cholesterol.  X-
ray scattering data show that cholesterol positions itself normal to the plane of the 
bilayer, with the hydroxyl group near the ester carbonyl of the phospholipid [4].  
Raman scattering data shows that no hydrogen bond is formed with this carbonyl 
group [5].  Cholesterol is known to have a dual role in terms of membrane 
fluidity.  Cholesterol acts to fluidize solid-like membranes, but reduces the 
fluidity of liquid-like membranes.  This behavior is well known, but the cause is 
less certain.  2H-NMR experiments show that cholesterol strongly affects the 
order parameter along the length of the phospholipid hydrocarbon chain [6].  FT-
IR experiments have shown that above the main transition temperature, 
cholesterol decreases the amount of gauche rotamers in the phospholipid 
hydrocarbon chain, and just the opposite is observed below the main transition 
temperature [7].   
2.2.2 Maximum Solubility and Nucleation  
Cholesterol alone is not capable of forming a stable bilayer.  Thus, there is 
a maximum solubility of cholesterol in phospholipid bilayers.  Estimates of the 
maximum solubility of cholesterol in phosphatidylcholine and 
phophatidylethanolamine bilayers have been recently reported to be 66-mole 
percent and 51-mole percent cholesterol respectively [8].  The maximum 
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solubility is a strong function of the head group size and charge, but independent 
of acyl chain length [8].  At cholesterol concentrations above the solubility limit, 
cholesterol monohydrate crystals constitute an additional equilibrium phase.  This 
macroscopic solubility limit is an apparent limit in the sense that the detection of a 
macroscopic cholesterol crystal in the aqueous phase does not preclude the 
membrane from having a certain capacity for stable crystals within the bilayer.  
Conceptually this is similar to the presence of a membrane on the CMC of a 
surfactant.  The mechanism by which cholesterol nucleates from cholesterol 
phospholipid bilayers is currently not well understood, but the finding of 
immiscible cholesterol domains suggests that crystalline cholesterol can exist in 
membranes.  Therefore it is reasonable to hypothesize that the membrane is the 
site of cholesterol nucleation, and once stable cholesterol nuclei are formed, the 
addition of more cholesterol causes the nuclei to grow to critical size and 
precipitate out of the membrane.  Crystal growth in the aqueous space is most 
likely the rate-limiting step for the optical detection of cholesterol crystals.   
2.3 Models for Cholesterol Distributions in Phospholipid Bilayers 
Several cholesterol distribution models of membrane structure have been 
proposed.  A discussion of these distribution models is given in the following 
subsections.   
2.3.1 Random Distribution Model 
The simplest model for how cholesterol distributes in phospholipid 
bilayers is a random distribution.  This model is applied successfully to 
 8
cholesterol phospholipid bilayers at low cholesterol concentrations.  At 
intermediate and high cholesterol concentrations, much evidence suggests that the 
distribution is not random [9]. 
2.3.2 Condensed Complex Model 
This model theorizes that cholesterol and phospholipids react at specific 
stoichiometric proportions to form a condensed complex; or a new liquid phase in 
equilibrium with the liquid disordered phase in cholesterol/phospholipid bilayers 
[10].  The cholesterol to phospholipid stiochiometries that have been proposed for 
these complexes are 1:4, 2:7, 1:3, 1:2, 2:3,and 1:1 [10].  In support of this theory, 
investigators have reported discontinuities in the fluorescence properties of 
various membrane probes as function of cholesterol composition in phospholipid 
cholesterol membranes that correspond to the putative complex compositions [11-
14]. 
2.3.3 Superlattice Model 
This theory hypothesizes that in cholesterol phospholipid membranes, 
cholesterol molecules stay as far apart from one another as possible, leading to 
non-random distributions.  The molecular interactions leading to these non-
random cholesterol distributions could be described as unfavorable cholesterol-
cholesterol interactions, or favorable cholesterol-phospholipid interactions.  The 
idea of cholesterol favoring phospholipids stems from the phospholipid head 
groups shielding the cholesterol hydroxyl groups from the aqueous space, and the 
favorable van der Waals interactions between the cholesterol molecule and the 
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phospholipid acyl chains.  The superlattice model proposes that lipids adopt non-
random lateral distributions in membranes, allowing only a limited number of 
compositions of each component in a membrane [15].  The superlattice 
arrangements are proposed to be energetically favorable packing configurations, 
making them minimum energy structures.  Therefore membrane compositions 
would tend to settle on a superlattice compositions rather than intermediate 
compositions [15].  These superlattice compositions are the compositions of 
laterally phase-separated domains that are in dynamic equilibrium with the bulk 
lipid phase [15].  Superlattice domains of different compositions can be in 
equilibrium with one another [15].   
2.4 Cholesterol and Phase Separation in Biological Membranes 
Up to 90% of all cholesterol can be found in the plasma membrane of 
mammalian cells [16].  The cholesterol content of animal cell plasma membranes 
has been estimated to be between 25 mole% and 50 mole% cholesterol [17].  
Cholesterol phospholipid interactions in terms of lateral phase separations could 
play an important role in biological membrane structure and function.  Laterally 
phase separated domains known as rafts are hypothesized to exist in biological 
membranes, and are thought to be important for protein sorting, lipid sorting, and 
protein stabilization [18].  Membrane fragments called “detergent resistant 
membranes” (DRMs) have been isolated from natural membranes [18].  These 
DRMs are believed to be evidence of rafts in natural membranes.  Furthermore, 
recently reported immiscible cholesterol domains in natural and model 
membranes are evidence of lateral phase separations in membranes [19].   
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2.4.1 Rafts 
Rafts are thought to be discrete laterally phase separated functional 
domains in equilibrium with the fluid phase in cell membranes.  This is the origin 
of the term raft, where the discrete phase are “rafts” floating in an ocean of the 
continuous phase. Rafts are hypothesized to exist in biological membranes, and 
are thought to be involved in protein sorting and lipid sorting, as well as protein 
stabilization [18].  The functions of rafts involve the selective partitioning of 
specific lipids and proteins into these discrete phases and the facilitation of 
interactions between them, for example proteins that need to work together may 
co-locate within a raft domain as opposed to randomly diffusing around the 
membrane surface.  Alternatively, ordered lipid microenvironment like in 
cholesterol-sphingomyelin rafts may effect protein conformations and thus 
function.  Cholesterol and sphingomyelin rafts are thought to functionally 
important in animal cell plasma membranes [20]. 
2.4.2 Detergent Resistant Membrane Fragments 
Detergent resistant membranes (DRM) are fragments of natural plasma 
membranes found to be resistant to detergent solubillization.  Since detergents 
solubilize “fluid-like” membranes, these fragments are evidence that biological 
membranes are not all in the liquid crystalline state [18].  When analyzed, these 
DRM, were found to be enriched with both cholesterol and sphingomyelin [18].  
The acyl chains in these detergent resistant membrane fragments were in a state 
similar to acyl chains in the liquid ordered state found in model membrane 
systems [18].  As may be expected, liquid ordered phases from model membrane 
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systems also show partial resistance to detergent solubility [18].  Therefore, 
detergent resistant membrane fragments have been the best experimental evidence 
for the existence of lipid rafts in biological membranes.  However, because single-
phase membranes with properties intermediate to the liquid ordered and the liquid 
crystalline phases have shown partial detergent insolubility, DRM do not serve as 
proof that rafts exist [18].   
2.4.3 Immiscible Cholesterol Domains 
There has been a recent report of a tail-to-tail cholesterol only bilayer 
phase in natural membranes detected by small angle X-ray diffraction, this phase 
was shown to be reversibly disrupted and reformed by heating and cooling [19].  
The presence of these immiscible cholesterol domains appeared at cholesterol to 
phospholipid ratios above 0.8:1 in extracted smooth muscle cell membranes [19].  
An increase in the bilayer thickness preceded the formation of these immiscible 
cholesterol domains [19].  Existence of immiscible cholesterol domains was also 
demonstrated in a phospholipid-cholesterol model membrane system at 
cholesterol to phospholipid ratio of 1:1, by the same small angle X-ray diffraction 
technique [19].  These immiscible cholesterol domains fall under the general 
description of rafts, being a dispersed phase in a continuous phase, but are 
fundamentally different than other proposed raft structures in that they are 
comprised only of cholesterol.  Immiscible cholesterol domains may have 
important roles in cholesterol related diseases like gallstone disease, and heart 
disease serving as nuclei for cholesterol monohydrate crystals.   
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2.5 Multi Lamellar Vesicle (MLV) preparation 
We are studying cholesterol induced laterally phase separated cholesterol 
domains and are interested in knowing if sample preparation techniques have an 
effect on the formation and properties of these domains.  The two MLV 
preparations techniques that will be utilized and compared in this project are the 
film deposition method and the modified rapid solvent exchange method.  The 
details of these two methods are explained in the following subsections.   
2.5.1 Film deposition method 
In the film deposition method of MLV preparation phospholipids and 
cholesterol are dissolved in organic solvents such as chloroform to form stock 
solutions.  Appropriate amounts of these stock solutions are mixed to give the 
desired lipid and cholesterol concentrations.  The solvents are then typically 
removed under a stream of nitrogen.  Sometimes the resulting films are placed 
under a vacuum to remove any residual solvent.  The deposited lipid films are 
then hydrated in aqueous buffer.  This technique is currently in wide use despite 
recent evidence that cholesterols and phospholipids can potentially de-mix in the 
solid film state, and may give rise to cholesterol crystals below the macroscopic 
cholesterol solubility limit [21].   
2.5.2 Modified rapid solvent exchange method 
The method of rapid solvent exchange involves the direct transfer of lipids 
and cholesterol from an organic solvent directly to an aqueous buffer.  This is 
achieved by mixing the lipids and cholesterol in chloroform directly into aqueous 
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buffer, and the two-phase mixture is vortexed under a vacuum to remove the 
organic phase.  The original technique involved injecting the lipids and 
cholesterol in the organic phase into the evacuated volume of the vortexing 
aqueous buffer [21], but was later modified to directly mixing the aqueous and 
organic phases before vortexing and applying vacuum [22].   
2.6 Fluorescence Spectroscopy  
Fluorescence spectroscopy is a useful tool in investigating membrane 
phase behavior.  Fluorescent membranes probes depending on their structure can 
partition into different regions of a membrane.  Fluorescent probes incorporated 
into membranes can be detected in as low as pico-molar amounts [1].  There are 
two types of fluorescence spectroscopy, steady-state and time-resolved, and 
different information can be obtained from each.  A technique in fluorescence 
spectroscopy called fluorescence resonance energy transfer (FRET) allows the 
measurement of distances on the nanometer length scale.  This ability has led to 
the widespread use of FRET as a spectroscopic ruler [23].   
2.6.1 Steady-State Fluorescence Spectroscopy 
In steady state fluorescence the sample is excited with a continuous light 
source and the emission intensity is measured for a finite time period on the order 
of seconds.  During this finite time period fluorescent molecules called 
fluorophores are excited repeatedly and decay repeatedly, and the measured 
fluorescence intensity is an average of all of the excitations and decays of all of 
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the fluorophores in the path of the light source.  Thus steady state fluorescence 
spectroscopy yields sample-averaged spectra.   
2.6.2 Time Resolved Fluorescence Spectroscopy 
In time resolved fluorescence spectroscopy the sample is excited with a 
short pulse of light at a specific wavelength, and the fluorescence intensity of 
emission at a specific wavelength is measured as a function of time, on the 
nanosecond scale, after the excitation.  This is called the fluorescence decay.  
Fluorescence decays are analyzed by proposing physical models for the 
fluorescence decay function.  These models are fit to the experimental data to 
extract the model parameters.  Time resolved spectroscopy has the ability to 
distinguish between different populations of fluorophores in the same sample.  If 
fluorescent molecules are in a homogeneous environment, then a single 
exponential decay model is expected to describe the fluorescence decay: 
I t( ) exp( t / )= −α τ         (1) 
where α is a constant proportional to intensity of the excitation source, and τ is 
the fluorescence lifetime of the fluorophores in the sample.  Qualitatively, the 
fluorescence lifetime is the average time the fluorophores spend in the excited 
state, and is a strong function of the physical environment of the fluorophores.  
Likewise if fluorophores are partitioned between two distinct environments within 
a sample, then a double exponential decay model describes the fluorescence 
decay: 
I t t t( ) exp( / ) exp( / )= − + −α τ α τ1 1 2 2      (2) 
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where the α’s are proportional to the fractions of fluorophores in each 
environment, and the τ’s are the decay times in each environment.   
2.6.3 Analysis of Time Resolved Fluorescence Spectroscopy 
Two experiments must be conducted to calculate fluorescence decay 
parameters.  The first experiment is the acquisition of the samples measured 
response M(t).  The second experiment is the acquisition of the instrument 
response function L(t).  The instrument response function represents the response 
of the lamp pulse and the electronics of the detection system.  The measured 
response M(t) is the convolution of the fluorescence decay I(t) with the instrument 
response function L(t).  The fluorescence decay function is calculated by a 
method called iterative re-convolution.  In iterative re-convolution a mathematical 
model of the fluorescence decay function is proposed and this model is 
numerically convoluted with the instrument response function to yield a 
calculated response function C(t).  Then the calculated response function is 
compared to the measured response function, and the parameters of the decay 
model are varied until a best fit of the calculated response to the measured 
response is obtained.  The quality of fit is judged by the value of the chi squared 
(χ2) parameter defined as: 
χ σ
2
2
1
21= −
=
∑
kk
n
M t C t( ( ) ( ))        (3) 
where n is the total number of discrete data points, k is the kth point, σk is the 
standard deviation of the kth point, M(t) is the measured response, C(t) is the 
calculated response 
 16
A fit is considered to be good if χ2 is between 0.9 and 1.2.  Another determination 
of the quality of the fit is a plot of the weighted residuals.  If there is a systematic 
deviation in the residuals then the model should be rejected. In model-based 
analysis it is not possible to validate a decay model, but is possible to reject decay 
models on their failure to adequately describe the data.   
2.6.4 Time Resolved Emission Spectroscopy (TRES) 
Time resolved emission spectroscopy is a useful tool for studying the 
dynamics of macromolecules.  Time resolved emission spectra (TRES) represent 
the fluorescence emission spectra as a function of time during the decay of 
fluorescence from the excited state to the ground state.  TRES is particularly 
useful in the study of the interactions of polar fluorophores with their 
environment.  With TRES it is possible to decouple the effects of solvent polarity 
and dipolar relaxation, or the molecular motions of the solvent and fluorescent 
probe molecules.   
2.7 Fluorescence Resonance Energy Transfer (FRET) 
FRET is the migration of excited state energy from an initially excited 
donor molecule to an acceptor molecule.  The energy transfer results from an 
intermolecular long-range dipole-dipole coupling interaction.  These interactions 
can transfer excited state energy over distances of about 10 to 100 angstroms [24]. 
The efficiency of energy transfer is a function of the separation distance between 
the donor and the acceptor molecules, the degree of overlap of the donor emission 
spectra with the acceptor adsorption spectra, the quantum yield of the donor, and 
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the relative orientation of the transition dipoles [25].  The rate of energy transfer 
is given by 
k
R
rT D
= 


1 0
6
τ         (4) 
where τD is the fluorescence lifetime of the donor without the acceptor, and R0 is 
called the Forster distance, which is the distance at which the efficiency of energy 
transfer is 50%.  The Förster distance can be calculated from the following 
equation: 
(R n QD0 3 2 49 78 10= × −. κ )J ( )λ
dλ
      (5) 
where κ is the orientation factor, n is the refractive index of the medium, QD is the 
quantum yield of the donor molecule.  J(λ) is the overlap integral and quantifies 
the spectral overlap of the donor emission and acceptor adsorption.  The overlap 
integral can be calculated by 
J FD A( ) ( ) ( )λ λ ε λ λ=
∞
∫ 4
0
       (6) 
where FD(λ) is the normalized emission spectra of the donor, λ in the wavelength, 
and εA is the extinction coefficient of the acceptor.   
The efficiency of energy transfer can be calculated as 
E
k
k
T
D T
= +−τ 1          (7) 
Finally using the expression for the rate of energy transfer, the efficiency can be 
recast in terms of the Forster distance and the separation distance of the donor and 
acceptor molecules.   
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E
R
R r
= +
0
6
0
6 6          (8) 
This theory is based on a single donor and a single acceptor pair at a fixed and 
does not apply to donors and acceptors that are free to diffuse.   
2.8 FRET in Membranes 
Classical FRET is well established as a “spectroscopic ruler” for 
measuring the fixed distance between physically linked donors and acceptor 
molecules [26].  In membranes molecules are free to diffuse, thus energy transfer 
donors and acceptors are not at a fixed distance.  In biological membranes 
typically fluorescent groups are attached to lipid molecules and energy transfer 
can occur from donors to multiple acceptors, and each donor will have a different 
distribution of acceptors around it.  In this scenario the concentration of acceptors 
and the lateral distribution of lipids and phases become the significant factors, and 
the notion of separation distance does not apply.  If the donors and acceptors are 
able to diffuse significantly during the excited state lifetime of the donor, then 
energy transfer theory becomes very complex.  Analytical solutions exist for a 
few special cases, and Monte-Carlo methods are used to investigate more 
complex situations.   
2.8.1 Homogeneous solution theory 
For situations where the donors and acceptors are immobile during the 
excited state lifetime of the donor, and if the Forster distance is small enough to 
neglect energy transfer across the bilayer then the energy transfer theory for 
unlinked donors and acceptors randomly distributed in a 2-D homogenous 
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solution has been applied to membranes [27].  The donor fluorescence decay 
function in the presence of acceptors is calculated as: 
I t
t
c
t
DA
D D
( ) exp
/
= − − 







 τ τ
1 3
      (9) 
where c is a constant related to the surface density of the acceptors [27].  
2.8.2 Theory for known probability distributions 
Analytical solutions exist for known probability distributions for immobile 
donors and acceptors in bilayers that account for excluded area around the donors, 
transfer across the bilayer, and membrane curvature [23,28].  The general form of 
the donor fluorescence decay function is 
I t I S tDA DA( ) exp[ ( )]= − ⋅0 σ        (10) 
where S(t) represents the portion of the decay due to energy transfer.   
S(t) for a random distribution in 2-D is infinite plane with a distance of closest 
approach rC is given by the expression. 
S t t R r rdrD
rC
( ) [ exp[ ( / )( / ) ]]= − − ⋅
∞
∫ 1 0 6τ 2π      (11) 
The efficiency of energy transfer E is then calculated by integrating the donor 
fluorescence decay function in the presence of acceptors and the donor 
fluorescence decay function in the absence of acceptors according to: 
E
I t d
I t dt
DA
D
= −
∞
∞
∫
∫
1 0
0
( )
( )
t
        (12) 
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where ID(t) is the donor decay function in the absence of energy acceptors, and is 
given by equation (1) assuming the donor decay is single exponential.   
2.8.3 Non-random distributions 
Analytical solutions do not exist for complex multi-phase membrane 
systems.  Systems of arbitrary complexity can be studied by using Monte-Carlo 
methods [29].  Monte-Carlo methods are used to simulate species and probe 
distributions in the membrane.  The simulated fluorescence decay is calculated 
using the FRET theory for a donor-acceptor pair at a fixed distance, and adding 
up the contributions from every donor and acceptor distance in the system to 
generate the decay function.  The decay law for a donor j ρjDA(t) in the presence 
of multiple acceptors at various distances is given by: 
ρ τ τjDA i i
i
jkk
N
t
t t R
R
A
( ) exp exp= −


−












=∏ 0
6
1
     (13)
 
where τi is the fluorescence lifetime of the donor in environment i without the 
presence of the acceptors, NA is the total number of acceptors, R0i is the Forster 
distance in environmenti, Rjk is the distance between donorj and acceptork, and ND 
is the number of donors.  The decay function IDA(t) for donors in the presence of 
the acceptors is obtained by summing up all the contributions from all the 
acceptors to each donor: 
I t
N
tDA
D
jDA
j
N D
( ) ( )=
=
∑1
1
ρ
       (14)
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The donor only decay function assuming single exponential decay is described by 
equation (1).  Once the decay functions are generated the efficiency of energy 
transfer is calculated using equation (12) by numerically integrating the simulated 
decay curves. 
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Figure 2.1 Diagram of lipid phases for pure phospholipids in excess water. 
 
 23
List of References 
 
[1]  Gennis, 1989. Biomembranes Molecular Structure and Function. Springer-
Verlag. New York. 
 
[2]  J.A. Lucy, Q.F. Ahkong, 1986, An Osmotic Model for the Fusion of 
Biological Membranes.  FEBS Lett. 199, 1-11. 
 
[3]  L. M.S. Loura, A. Fedorov, M. Prieto, 2001, Fluid-Fluid Membrane Micro 
heterogeneity: A Fluorescence Energy Transfer Study, Biophysical J., 80, 776-
788. 
 
[4]  D.L. Worcester, N.P. Franks, 1976, Structural Analysis ofnHydrated Egg 
Lecithin and Cholesterol Bilayers 2 Neutron Diffraction. J.Mol. Biol. 100, 359-
378. 
 
[5]  S. F. Bush, R.G. Adams, I.W. Levin, 1980, Structural Reorganizations in 
Lipid Bilayer Systems: Effect of Hydration and Sterol Addition on Raman 
Spectra of DPPC Multilayers. Biochemistry 19, 4429-4436. 
 
[6]  E. Oldfield, D. Chapman, 1972, Dynamics of Lipids in Membranes: 
Heterogeneity and the Role of Cholesterol. FEBS Lett. 23, 285-297. 
 
[7]  M. A. Cortijo, A. Alonzo, J.C. Gomez-Fernandez, D. Chapman, 1982, 
Intrinsic Protein-Lipid Interactions: Infrared Spectroscopic Studies of Gramacidin 
A, Bacteriorhodopsin, and Ca2+-ATPase in Biomembranes and Reconstituted 
Systems. J. Mol. Biol. 157, 597-618. 
 
[8]  J. Huang, J.T. Buboltz, G.W. Feigenson, 1999, Maximum solubility of 
cholesterol in phosphatidylcholine and phosphatidylethanolamine bilayers. 
Biochim, Biophys, Acta, 1417. 89-100. 
 
[9]  P. Lee, G. Chong, 1994, Evidence for Regular Distribution of Sterols in 
Liquid Crystalline Phosphatidylcholine Bilayers. Proc. Nat. Acad. Sci. U.S.A. 91. 
21. 10069-10073. 
 
[10]  A. Radhakrishnan, H.M. McConnell, 1999, Condensed Complexes of 
Cholesterol and Phospholipids. Biophysical J. 77, 1507-1517. 
 
[11]  J.A. Vitranen, M. Ruonala, M. Vauhkonen, P. Somerharju, 1995. Lateral 
organization of liquid-crystalline cholesterol-dimyristroyl phosphatidylcholine 
bilayers. Evidence for domains with hexagonal and centered rectangular 
cholesterol superlattices. Biochemistry. 34, 11568-11581. 
 
 24
[12]  M.M. Wang, I.P. Sugar, P.L. Chong, 1998, Role of the sterol Superlattice in 
the partitioning of the antifungal drug nystatin into lipid membranes. 
Biochemistry. 37, 11797-11805. 
 
[13]  D. Tang, W. van Der Meer, S.-Y.S. Cheng, 1995, Evidence for a regular 
distribution of cholesterol in phospholipid bilayers from diphenylhexatriene 
fluorescence. Biophysics J., 68, 1944-1951. 
 
[14]  T. Parassassi, A.M. Giusti, M. Raimondi, E. Gratton, 1995, Abrupt 
modifications of phospholipid bilayer properties at critical cholesterol 
concentrations. Biophysics J., 68, 1895-1902. 
 
[15]  P. Somerharju, J.A. Virtanen, K.H. Cheng,1999, Lateral Organization of 
Membrane Lipids: The Superlattice view. Biochim, Biophys, Acta. 1440, 32-48. 
 
[16]  Y. Lange, B.V. Ramos, 1983, Analysis of the distribution of cholesterol in 
the intact cell. J. Biol. Chem. 258. 15130-15134. 
 
[17]  K. Bloch, 1991, Cholesterol: The evolution of structure and function in: 
D.V. Vance, J.E. Vance, Biochemistry of Lipids, Lipoproteins and Membranes. 
Elsevier, Amsterdam. Pp. 363-381. 
 
[18]  D.A. Brown, E. London, 1998, Functions of Lipid Rafts in Biological 
Membranes. Annu. Rev. Cell Dev. Biol. 14, 111-136. 
 
[19]  T. N. Tulenko, M. Chen, P. E. Mason, and R. Preston-Mason, 1998. 
Physical effects of cholesterol on arterial smooth muscle membranes: evidence of 
immiscible cholesterol domains and alterations in bilayer width during 
atherogenesis. J. Lipid Research. 39:947-956. 
 
[20]  E. London and D. A. Brown, 2000. Insolubility of lipids in triton x-100: 
physical origin and relationship to sphingolipid/cholesterol membrane domains 
(rafts). Biochim, Biophys, Acta, 1508. 182-195. 
 
[21]  J. Buboltz, and G. W. Feigenson, 1999. A novel strategy for the preparation 
of liposomes: rapid solvent excgange. Biochimica et Biophysica Acta (BBA) - 
Biomembranes, 1417, 232-245. 
 
[22]  Tokumasu, F., Jin, A. J., Feigenson, G. W., Dvorak, J. A., 2003. Atomic 
force microscopy of nanometric liposome adsorption and nanoscopic membrane 
domain formation. Ultramicroscopy 97, 217-227. 
 
[23]  L. Stryer, 1978, Fluorescence Energy Transfer as a Spectroscopic Ruler, 
Annu. Rev. Biochem. 47, 819-846. 
 
 25
[24]  X. F. Wang and B. Herman, 1996, Fluorescence imaging spectroscopy and 
microscopy, Chemical Analysis Series Vol. 137. Wiley & Sons Inc., New York. 
 
[25]  J. R. Lakowicz, 1999, Principles of fluorescence spectroscopy, Plenum, New 
York. 
 
[26]  B. K.K. Fung, and L. Stryer, 1978. Surface density determination in 
membranes by fluorescence energy transfer. Biochemistry, 17,24:5241-5248. 
 
[27]  P. Lianos, G. Duportail, 1993, Time resolved fluorescence fractal analysis in 
lipid aggregates, Biophys. Chem. 48, 293-299. 
 
[28]  T.G. Dewey and G.G. Hammes. Biophys. J. 32 (1980) 1023-1035. 
 
[29]  B. Snyder, E. Freire,1982, Fluorescence Energy Transfer In Two 
Dimensions: A Numeric Solution for Random and Nonrandom Biophys. J., 40, 
137-148. 
 26
CHAPTER 3: Research Goals 
 
The goals of this research effort are the development of fluorescence 
techniques for the detection and characterization of laterally phase-separated 
cholesterol domains in model membranes.  We are also interested in the effects of 
laterally phase separated cholesterol domains on the molecular motions of water 
and phospholipids in the membrane.  To achieve these goals we will apply 
fluorescence energy transfer methods for detection and characterization of 
laterally phase-separated domains in DMPC-cholesterol membranes, and time 
resolved emission spectroscopy to investigate the molecular motions of water and 
lipids in the membrane.  We will utilize a combination of fluorescent probes in 
the following specific objectives: 
 
 Detection and characterization of cholesterol domains in lipid membranes 
with DANSYL-PC and Förster resonance energy transfer methods in 
DMPC/cholesterol model membranes. 
 
 Analytical and numerical modeling of the lateral distribution of 
fluorescence energy transfer probes in membranes that exhibit lateral 
phase separations. 
 
 Application of time resolved emission spectroscopy to determine the 
mechanism of the DANSYL-PC spectral sensitivity to cholesterol and 
laterally phase separated domains.   
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CHAPTER 4: DANSYL Temperature Studies 
 
4.1 Introduction 
Evidence that natural membranes are not completely in a liquid crystalline 
state has emerged, leading to a hypothesis that laterally phase separated domains, 
termed ‘rafts,’ exist in natural membranes [1].  Rafts are hypothesized to play a 
role in signal transduction, protein stabilization, lipid and protein sorting, and 
membrane fusion [1-3].  Some of the evidence for the raft hypothesis comes from 
detergent resistant membranes (DRM), which are fragments of natural plasma 
membranes found to be resistant to detergent solubilization.  Analysis of the 
DRM reveals that they are enriched with both cholesterol and sphingomyelin [4].   
Owing to the cholesterol enrichment, the acyl chains of the lipids in these 
rafts appear to be in a state similar to the liquid-ordered (lo) phase, which has been 
positively identified in several model membrane systems comprising a single 
phospholipid species and cholesterol [5].  The lo phase occurs above a certain 
cholesterol loading, which varies with (e.g.) temperature and phospholipid 
species, and arises because of the well known ‘condensation’ effect of cholesterol 
[6].  The lo phase coexists with a liquid-disordered (ldo) phase over a certain 
composition range, and this coexistence implies a lateral phase separation within 
the membrane.  A similar lateral phase separation occurs in cholesterol-free 
membranes comprising multiple, but immiscible, phospholipid species such as the 
binary mixture of dimyristoylphosphatidylcholine (DMPC) and 
distearoylphosphatidylcholine. [7]. 
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Given their biological relevance, numerous physical chemical studies have 
been performed on monolayer and bilayer membranes comprised of 
phospholipids and cholesterol [6].  Surprisingly, a clear understanding of these 
membrane systems is lacking.  Indeed, the maximum solubility of cholesterol in 
lipid bilayers remains a matter of debate [8].  It is clear that lateral phase 
separation is possible in these systems and that immiscible, cholesterol-rich 
phases can and do form [9], but more recent evidence suggests that the well 
known lo phase does not tell the whole story.  For example, there is evidence that 
condensed complexes of cholesterol and phospholpids form and, under certain 
conditions, yield a separate phase within the membrane [10]. Additional evidence 
points to the existence of immiscible domains, or clusters, comprised entirely of 
cholesterol [11]. The latter cholesterol domains, which are not merely cholesterol-
enriched but are believed to comprise a pure (tail-to-tail) cholesterol bilayer phase 
as determined by small angle X-ray diffraction, are observed to ‘melt’ upon 
heating but form again spontaneously upon cooling, suggesting that they 
constitute an equilibrium membrane phase [11].   
The existence of pure cholesterol domains within membranes is a 
potentially very important finding.  One reason is that such domains would serve 
as sub-critical nuclei in biliary vesicles, the aggregation of which would facilitate 
rapid cholesterol nucleation when the pre-existing, but sub-critical, nuclei collide.  
This would account for the striking observation that vesicle aggregation is a 
prerequisite for nucleation of cholesterol crystals, regardless of the cholesterol 
loading, in gallstone pathogenesis [12].  A similar mechanism might also be at 
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play in atherosclerosis.  Cholesterol crystals are recognized as a hallmark of 
advanced atherosclerotic plaques [13], but the source of crystalline cholesterol is 
unknown.  There is evidence to suggest that cholesterol crystals nucleate from 
low density lipoproteins (LDL) in the extracellular space [14] and that LDL 
aggregation is observed to play an important role.  If pure cholesterol domains 
exist in the LDL monolayer, then the pro-nucleating effect of LDL aggregation is 
easily understood.   
We are interested in cholesterol nucleation from biological colloids and 
developed the first fluorescence assay that detects cholesterol nucleation from 
phospholipid-cholesterol vesicles [15].   The assay involves energy transfer from 
dehydroergosterol (ERGO) to dansylated lecithin (DANSYL), which are 
fluorescent analogs of the native lipids cholesterol and phosphotidylcholine, 
respectively.  We have used the assay to quantify nucleation in the presence of the 
pro-aggregating enzyme, phospholipase C [15] and the bile salt, sodium 
taurocholate [12].  In developing the assay for nucleation, we observed evidence 
of what we described as a possible “lateral phase separation of cholesterol and 
ERGO within the vesicle bilayer” which, if present, could be viewed as “the first 
step in nucleation” [15]. We now show further evidence for the existence of pure 
cholesterol domains in phospholipid-cholesterol membranes.   
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4.2 Theory 
Fluorescence resonance energy transfer is well described for systems 
comprising single donor and acceptor pairs at a fixed distance. The situation in 
membranes is more complex and involves energy transfer from donors to multiple 
acceptors.  Moreover, a different distribution of acceptors surrounds each donor, 
and these complexities must be considered when evaluating energy transfer in the 
present study.   
Theories exist for known probability distributions of acceptors around 
donors in membrane bilayers that account for excluded area around the donors, 
transfer across the bilayer, and membrane curvature [16,17].  Briefly, the theories 
state that the general form of the donor fluorescence decay function is: 
 
)](exp[)/exp()( 0
0 tStItI DADA ⋅−−= στ      (1) 
 
where I0DA is the initial fluorescence intensity of the donor in the presence of an 
acceptor, IDA(t) is the fluorescence intensity of the donor in the presence of an 
acceptor at any time, t, τ0 is the fluorescence lifetime of the donor in the absence 
of acceptor, σ is the acceptor surface density, and S(t) represents the portion of the 
decay due to energy transfer.  For a random distribution in two-dimensional 
infinite plane, S(t) is given by  
 
∫∞ ⋅−−=
a
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where the lower limit of integration, a, is the so-called ‘distance of closest 
approach’ and is estimated to be the average molecular diameter of the donor and 
acceptor molecules.  R0 is the Förster distance, which is ~50 Å for the ERGO-
DANSYL pair, and r is the actual distance between the donor and acceptor.  The 
efficiency of energy transfer, E, is then calculated the ratio of IDA(t) and the donor 
fluorescence decay function in the absence of acceptors, ID(t), according to: 
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ID (t) is often best described by a single exponential decay.  Combination of Eqs. 
1-4 than gives the efficiency of energy transfer from a donor to a random 
distribution of acceptor, within an infinite plane. 
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We now extend this theory to account for lateral phase separation of 
cholesterol-rich domains in membranes and make four simplifying assumptions: 
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1) donors are at the center of domains 2) acceptors are completely excluded from 
the domains, 3) the shape of the domains is disk-like, and 4) the domains are 
symmetric along the plane of the bilayer.  Energy transfer results from donors in 
the center of discrete domains to acceptors in the continuous phase and from 
donors in the continuous phase to acceptors in the continuous phase, and the 
efficiency of energy transfer is calculated for a donor in each environment.  The 
observed efficiency of energy transfer is the weighted average of the efficiency of 
energy transfer in each environment based on the relative fractions of donors in 
each phase.  The two donor environments are shown schematically in Fig. 4.1. 
 
The situation is described mathematically by Eq. 6, which now includes an 
additional term to account for energy transfer across a bilayer of thickness h. 
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The two limits of integration (LL1 and LL2) depend on the type of phase 
in which the energy transfer takes place.  The ‘distance of closest approach’ of the 
donor and acceptors in the continuous phase is approximately the average 
molecular diameter of the donor and acceptor, (so LL1=a), while in the domains 
the ‘distance of closest approach’ equals the domain radius n.(LL1=n)  In the 
continuous phase acceptors can reside directly beneath a donor so that LL2 is 
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given by the bilayer thickness h.  When a donor is in a domain, which acceptors in 
the opposite monolayer are restricted and LL2 is given as (n2+h2)1/2 .   
 
Given this description of E in each phase, all that remains is to estimate 
the relative amounts of each phase.  Specifically, it is necessary to know the 
relative amounts of donor in each phase.  By material balance, the relative amount 
of donor in the continuous phase is  
 
)*/( CCDDCC XXKpKpX +−=φ       (8) 
 
where XC is the mole fraction of lipids in the continuous phase and KpD is the 
donor partition coefficient.(KpD = xD2/xD1) 
 
The predicted efficiency of energy transfer (EPRED) is then a weighted 
linear combination of energy transfer in the continuous (EC) and discrete (ED) 
phases.   
 
DCCCPRED EEE ⋅−+⋅= )1( φφ       (9) 
 
The only unknowns in the above model are the distance of closest approach and 
the donor partition coefficient.  We anticipate that if cholesterol domains are 
present, then the donor will have a strong preference for the domains.  
Accordingly have set the value of KpD to 50.  We will show that the choice of 
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KpD does not impact the conclusions of this study, and only slightly affects the 
estimated domain sizes.  Thus the only fitted parameter in the study is the distance 
of closest approach.  The model will be used to test for domains in the following 
manner.  If no domains are present, the maximal efficiency of energy transfer will 
be relatively high, and the distance of closest approach will be on the order of one 
molecular diameter.  In the event that domains are formed, an estimate of their 
size will be obtained via a best (i.e. minimized least squares) fit of the domain 
radius, n.   
 
Footnote: 
The presence of domains in this study is determined not from energy transfer but 
from analysis of the DANSYL emission properties in the absence of ERGO.  The 
energy transfer model described herein is used as a complementary technique to 
confirm the existence of the domains and to provide and estimate of their size. 
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4.3 Materials and Methods 
4.3.1 Chemicals 
DMPC, Cholesterol, ERGO, Chloroform, Methanol, Egg-PC, KCl, NaN3, 
Na2HPO4, NaCl, CaCl2, and HEPES were purchased from Sigma Chemical Co. 
(Sigma-Aldrich Saint Louis, MO).  DANSYL was purchased from Avanti Polar 
Lipids, Inc. (Alabaster, AL).  Lipids and chemicals were used without further 
purification. 
4.3.2 Preparation of multilamellar vesicles (MLV) 
Stock solutions of DMPC, cholesterol, and ERGO were dissolved 
separately in chloroform to give final concentrations of 5mg/mL, 1mg/mL, and 
5mg/mL respectively.  DANSYL was dissolved in methanol to yield a stock 
solution concentration of 1mg/mL.  The stock solutions were mixed in varying 
proportions so as to give the described compositions (listed in Table 1).  The 
mixing was done in 20mL scintillation vials, and the solvent removed under a 
stream of nitrogen in a rotary evaporator.  The samples were then placed in a 
vacuum oven at room temperature and vacuum of 28 inches of Hg for 24 hours.  
After solvent removal the lipid films were hydrated with the appropriate amount 
of buffer to give a total concentration of 0.05mg/mL.  Samples were then vortex 
mixed for 5 minutes followed by indirect bath sonication at 30°C for 15 minutes.  
The buffer used for the DMPC experiments was 10mM phosphate buffer, pH 7.3, 
containing 50mM KCl and 0.02wt % NaN3.  The buffer used for the Egg-PC 
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experiments was 0.15M NaCl, 5mM CaCl2, 5mM HEPES, and 0.02wt% NaN3, 
pH=7.3. 
Three sets of samples were prepared.  Set A comprised Egg-
PC/cholesterol mixtures with cholesterol mole loadings varying from 0 to 65%.  
To these mixtures the DANSYL labeled lipids were added to give a ALR of 0.03.  
Set A was analyzed by a DANSYL temperature study in order to detect the 
presence of lateral phase separations.  Set B comprised DMPC-cholesterol 
mixtures with cholesterol mole loadings varying from 0 to 50 mole%.  To these 
mixtures the DANSYL labeled lipid was added to give a DANSYL(acceptor) to 
lipid ratio (ALR) of 0.03.  Set B was analyzed by a DANSYL temperature study 
to detect the presence of lateral phase separations.  Set C comprised of 40mole% 
cholesterol DMPC mixtures in which 5% of the total sterol was substituted with 
ERGO, mixed with varying amount of DANSYL to give ALR ratios ranging from 
0 to 0.10.  Set C was analyzed by FRET in order to measure the efficiency of 
energy transfer and to provide an estimate of any detected domains.  The samples 
sets prepared in this study are summarized in table 1.0. 
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Table 4.1 Summary of sample mixtures, compositions and experimental analysis 
used in this study 
 
 Mixture DANSYL ERGO Mole %Cholesterol ALR Analysis 
A Egg-
PC/Ch  
yes no 0,10,20,30,40,45,50,
55,60,65 
 
0.03 DANSYL 
T-Study 
B DMPC/Ch yes no 0,5,10,15,20,25,35,4
0,45,50 
 
0.03 DANSYL 
T-Study 
C DMPC/Ch yes yes 40 
 
0,0.02,0.04
, 
0.06,0.08,0
.10, 
0.12 
 
FRET 
ALR-Study 
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4.3.3 Fluorescence Experiments 
All fluorescence measurements were made using a steady state 
fluorescence spectrometer (Photon Technology International, Ontario Canada, 
model Q-5/W-601).  The temperature of the sample chamber was controlled to 
±0.5°C via a circulating water bath, and the temperature was continuously 
monitored with a cuvette thermometer (Fisher Corp., Philadelphia, PA. model # 
15-078J).   
4.3.4 DANSYL Temperature Study:(sets A & B) 
The DANSYL fluorescence emission spectrum was recorded for each 
sample in sets A and B as a function of temperature.  For samples in set C, the 
temperature was varied from 28°C to 48°C in 10°C intervals.  For the samples in 
set B the temperature was varied from 30°C to 60°C in 5°C intervals, except with 
the fifteen, twenty and twenty-five mole percent cholesterol samples, for which 
the temperature was varied in 1°C intervals.  The difference in temperature range 
between the two sets relates to the difference in the main transition temperature 
for the different phospholipids used (i.e. 24°C for DMPC and an average if 11°C 
for Egg-PC). The DANSYL labeled MLV were excited at 300nm, and the 
emission spectrum was recorded in the wavelength range 400nm to 550nm.  Fig. 
4.2 shows the DMPC/cholesterol compositions and temperatures used in this 
study indicated as filled circles superimposed on the experimental phase diagram 
determined by Almida and colleagues [18]. 
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4.3.5 FRET Efficiency as a function of acceptor loading: (set C) 
The ERGO emission was recorded as a function of DANSYL loading at 
30°C and 60°C for set C.  The acceptor to lipid ratio was varied from 0.00 to 0.12 
in the 40mole% cholesterol DMPC MLV.  The ERGO and DANSYL labeled 
MLV were excited at 300nm and the emission was recorded in the wavelength 
range 325nm to 550nm.   
4.3.6 Analysis of experimental data 
DANSYL emission spectra were smoothed and the absolute maximums 
were identified [19].  The data shown in Figs.  4.3 and 4.4, are the averages of 
five measurements taken over a ten minute period at each temperature.   
The experimental efficiency of energy transfer, Emeas, is determined from 
measured steady state fluorescence intensities according to: 
D
DA
meas F
FE −= 1         (10) 
 
where FDA is the ERGO fluorescence emission intensity at 373nm in the presence 
of DANSYL, and FD is the ERGO fluorescence emission intensity at 373nm in 
the absence of DANSYL. 
The measured lo / ldo phase boundaries were determined by fitting the DANSYL 
emission maxima as a function of temperature in a piecewise continuous fashion.  
For a given cholesterol loading, the temperature corresponding to the 
discontinuity in the piecewise curve fit was varied.  The temperature which 
yielded the best fit to the data, minimizing errors via, the method of least squares, 
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was identified as the lo to ldo transition temperature at the given cholesterol 
loading.   
4.4 Results 
4.4.1 DANSYL T-Studies Egg-PC MLV’s (set A) 
Fig. 4.3 shows the DANSYL fluorescence emission spectra for Egg-PC 
MLV as a function of cholesterol loading at room 28°C.  In the absence of 
cholesterol, the DANSYL emission maximum occurs at 515nm.  The DANSYL 
emission maximum remains fixed until the cholesterol loading of 30mole%.  
Beyond 30mole% cholesterol, the DANSYL emission maximum decreases (i.e. 
blue shifts).  By 65mole% cholesterol, the DANSYL emission maximum has 
decreased to 470nm.  The DANSYL emission maxima respond to heating (i.e. a 
temperature jump from 28ºC to 48ºC differently depending on the cholesterol 
loading.  Fig. 4.4 shows the DANSYL emission maximum as a function of 
cholesterol loading at 28ºC and 48ºC, and the data are separated into three distinct 
zones.  Zone Ι spans from 0mole% to 30mole% cholesterol,  Zone ΙΙ spans from 
30mole% to 55mole% cholesterol, and Zone ΙΙΙ continues from 55mole% to 
65mole% cholesterol.  Zone Ι is characterized by a slight blue shift in the 
DANSYL emission maximum as a function of cholesterol at 28ºC, with a small 
increase in the DANSYL emission maxima upon heating to 48ºC.  In Zone ΙΙ the 
DANSYL emission maxima show an increasing blue shift as a function of 
increased cholesterol loading at 28ºC.  Upon heating to 48ºC the DANSYL 
emission maxima in Zone ΙΙ (red) shift to longer wavelengths.  Zone ΙΙΙ shows the 
blue shifted emission maxima that only slight increase as a function of increased 
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cholesterol loadings at 28ºC.  When heated to 48ºC the DANSYL emission 
maxima in Zone III little to no shift to longer wavelengths.  It is interesting to 
note that the 28ºC original profile of emission maxima verses cholesterol loading 
was recovered upon cooling.  Indeed, profiles nearly identical to those shown in 
Fig.4.3 for both 28ºC and 48ºC were obtained through three heating and cooling 
cycles.   
4.4.2 DANSYL T-Studies DMPC MLV(set B) 
Given that Egg-PC contains a mixture of phospholipids (and hence a 
binary T vs. chol phase diagram does not apply) the above studies were carried 
out in a DMPC/Chol system.  The DANSYL emission maximum is shown in Fig. 
4.5 as a function of cholesterol loading at 30ºC and 60ºC for DMPC MLV’s.  As 
in the Egg-PC system, distinct zones emerge.  It is interesting to note that 
boundary between Zones I and II as drawn in Fig. 4.5, corresponds exactly to the 
lo / ldo phase boundary.  At 30°C in the absence of cholesterol the DANSYL 
emission maximum occurs at 511nm, and the DANSYL emission maximum 
steadily decreases as the cholesterol loading is increased to a value of 509nm at 
25mole% cholesterol.(Zone I)  Beyond 25mole% cholesterol the DANSYL 
emission maximum decreases sharply and somewhat linearly with added 
cholesterol until 40mole% at 30ºC.(Zone II).  Similar to the Egg-PC system, 
heating to 60ºC in Zone I causes a small yet noticeable increase (i.e. red shift) in 
the DANSYL emission maxima.  Also like the Egg-PC system, the magnitude of 
the red shift becomes more significant in Zone II.   
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4.4.3 Determination of Phase Boundaries In DMPC/Chol systems 
Upon closer examination of the red shift data in Zone I, it became 
apparent that the data might yield insights regarding the lo to ldo phase transition.  
Accordingly the DANSYL spectrum of three samples in Zone I, which contained 
cholesterol loadings (i.e. 15,20,25mole%) placing them in the two phase region 
(i.e. lo + ldo), were measured as a function of temperature in 1ºC intervals for each 
of these three samples.  Fig. 4.6 shows the DANSYL emission maximum versus 
temperature for each of these three samples.  Each sample exhibits a DANSYL 
emission profile that increases nearly linearly with cholesterol and then reaches a 
plateau.  The data for each cholesterol loading were fit with piecewise continuous 
functions and the temperature corresponding to the discontinuity was varied so as 
to achieve the best (i.e. least squared error) fits.  Best fits are shown as solid lines, 
and the temperature yielding the best fits are indicated (dashed lines) as points 
A,B,C for 15, 20, and 25 mole percent cholesterol respectively.  This point 
corresponds to the lo to ldo phase boundaries shown by ∆’s in Fig. 4.2.  Table II 
compares the lo to ldo phase boundary temperatures obtained by the DANSYL 
profiles in Fig. 4.6 with generally accepted values obtained by other techniques.   
4.4.4 FRET Studies DMPC FRET(Set C) 
To characterize length scale of the ERGO/DANSYL probe separation, 
FRET experiments were conducted accordingly.  The steady state fluorescence 
emission spectra were recorded for the 40mole% cholesterol DMPC MLV as a 
function of increasing DANSYL substitution; the measured efficiency of energy 
transfer was calculated according to equation 10.  DANSYL acceptor to lipid 
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ratio’s used in this study are listed in table 1.  The measured efficiency of energy-
transfer as a function of DANSYL acceptor to lipid ratio for the 40mole% 
cholesterol DMPC model membranes at 30ºC and 60ºC are shown in Fig. 4.7.   
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4.4.5 Domain model FRET calculations 
To test the hypothesis that cholesterol is randomly distributed in the 
membrane at 40mole% cholesterol in DMPC MLV the 30°C and the 60°C 
efficiency of energy transfer data as a function of acceptor to lipid ratio (ALR) 
was fit to equation 6.  In order to calculate the acceptor surface density σ from the 
ALR the average area per molecule must be estimated.  The average cross 
sectional area of a cholesterol molecule and a DMPC molecule is 38 Å2 and 68 Å2 
respectively [20,21].  Weighting the areas based on the cholesterol mole 
percentage gives and average area per molecule of 56 Å2 for a 40-mole% 
cholesterol membrane.  In the system studied ERGO is the donor and DANSYL is 
the acceptor.  The Forster distance for the ERGO and DANSYL is about 50 Å, 
and the ERGO unquenched fluorescence lifetime is on the order of 1 nanosecond 
[22].  The calculated efficiency of energy transfer as a function of ALR for 
different values of the distance of closest approach is shown in Fig. 4.8.  The 
30°C data was best fit by Eq. 6 with a distance of closest approach of 102 Å, 
while the 60°C data was best fit by Eq. 6 with a distance of closest approach of 96 
Å.   
To test for the presence of immiscible cholesterol domains Eqs. 6-9 were 
fit to the 30°C efficiency of energy transfer as a function of ALR data.  To use 
Eqs. 6-9 several model parameters must be estimated or experimentally obtained.  
The distance of closest approach in the continuous phase is estimated as the 
average of the molecular diameters of a cholesterol and DMPC molecule and is 
7.85 Å .  The bilayer thickness h is estimated to be 36 Å [21].  To determine the 
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fraction of donor in each phase, the phase boundaries and the donor partition 
coefficient must be known.  The phase boundaries of the putative domains are not 
known, assuming the domains are immiscible cholesterol domains then the right 
side phase boundary is unity.  To set a lower limit on the left side phase boundary, 
the lo / ldo phase boundary is used.  The phase boundaries of the putative 
immiscible cholesterol domains at 30°C are assumed to be xc1=0.28 and 
xc2=1.00, this gives the fraction the membrane in the continuous phase by the 
inverse lever rule at 40mole% cholesterol to be 0.833.  The phase boundaries of 
the putative immiscible cholesterol domains at 60°C are assumed to be xc1=0.34 
and xc2=1.00, this gives the fraction the membrane in the continuous phase by the 
inverse lever rule at 40mole% cholesterol to be 0.896.  The calculated efficiency 
of energy transfer as a function of immiscible cholesterol domain radius with an 
assumed donor partition coefficient (KpD) equal to 50 is shown in Fig. 4.9.  The 
30°C data was best fit by an immiscible cholesterol domain radius of 110 Å.  The 
60°C data was best fit by as immiscible cholesterol domain radius of 111 Å with a 
KpD of 50.  The effect of the assumed donor partition coefficient on the best fit 
estimated domain radius for the 30°C fret data is shown in Fig. 4.9. 
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Table 4.2 DMPC/cholesterol phase boundaries determined by the DANSYL 
methodology described in the study compared to ESR data [9] and FRAP data 
[18] 
 
Mole 
%Cholesterol 
DANSYL Data °C ESR Data °C FRAP data °C 
15 42 42 42 
20 46 45 45 
25 48 47 55 
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4.5 Discussion 
4.5.1 DANSYL Temperature Studies 
The finding of this study was the identification of cholesterol domains.  
These domains were observed in Egg-PC systems, in which a blue shift in the 
DANSYL emission maximum was observed upon the addition of cholesterol.  
The blue shift was dose dependent, and results from a decrease in polarity with 
added cholesterol.  The decrease in polarity is not necessarily a direct 
consequence of the presence of cholesterol.  Rather the cholesterol likely acts 
indirectly via a condensation effect to inhibit passive diffusion and reduce the 
accessibility of DANSLY to water [23-26].  The effect of heating on the initial 
DANSYL blue shift indicated the presence of immiscible cholesterol domains.  
Not only were the changes observed reversible, which suggests an equilibrium 
phase, but also the red shift is not present at high (i.e. 65mole%) cholesterol.  
These results are consistent with melting of domains in Zone II.  The temperature 
of 48°C in Zone III is too low to melt the domains.  One possibility is that these 
results simply represent the well known lo to ldo phase transition in PC/Cholesterol 
membranes.  However, given the lack of a phase diagram for the mixture of PC’s 
inherent with Egg-PC, it is not possible to determine if this interpretation is 
accurate.   
Accordingly, the tests were repeated with DMPC/Cholesterol mixtures, a 
PC for which the phase-diagram (Temperature vs. Cholesterol) is known [18]. 
Comparing the DANSYL blue shift as a function of cholesterol loading with the 
experimental phase diagram for DMPC/Cholesterol mixture shows that the large 
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blue shift in the DANSYL emission maximum occurring beyond 30mole% 
cholesterol does not correlate with the lo / ldo two-phase region.   
Analysis of the DANSYL emission maximum heating curves for the 15, 
20, 25mole% samples that lie in the two-phase liquid ordered liquid disordered 
region show that the onset of the plateau in the DANSYL emission maximum as a 
function of temperature is consistent with lo to ldo phase transition boundary in the 
two phase region of Fig. 4.2.  The phase boundaries determined by the DANSYL 
breakpoints compared to ESR and FRAP data are shown in table 2.  The 
DANSYL results are consistent with phase boundaries determined by ESR and 
FRAP techniques [9,18].  These data clearly demonstrate the ability of the 
DANSYL probe to detect lateral phase separations in model membranes.   
4.5.2 FRET Studies 
Further supporting the existence of cholesterol domains comes from the 
efficiency of energy transfer data for the 40 mole% cholesterol in DMPC MLV as 
an increase in the efficiency of energy transfer (see Fig. 4.7) as a function of the 
acceptor to lipid ratio, upon heating from 30ºC to 60ºC.  Furthermore, the overall 
low efficiency (%E < 55%, see Fig. 4.7) of energy transfer observed for the high 
acceptor loadings used in this study shows that close proximity of ERGO and 
DANSYL is inhibited.  The increase in the efficiency of energy transfer upon 
being heated is consistent with an acceptor-poor laterally phase separated domain 
being partially melted and allowing closer ERGO to DANSYL contact at 60ºC 
thus accounting for the higher quenching when the domains are disrupted.  This 
interpretation is based on evidence that the acceptor poor domains separate the 
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donors in the domains from the acceptors in the acceptor-rich continuous phase.  
The melting of the domains allows closer contact of the probes and more efficient 
energy transfer.  Without a phase change the efficiency of energy transfer would 
remain constant as a function of increasing temperature for all acceptor-to-lipid 
ratios.  The DANSYL moiety is slightly polar, thus it will not preferentially 
partition into a cholesterol-rich condensed phase, thus lending to the acceptor-
poorness of the cholesterol domains.   
4.5.3 FRET Modeling 
Analysis of the efficiency of energy transfer data as a function of acceptor 
loading can provide insight on the size of the laterally phase separated domains.  
The random distribution model (Eqn. 6) with a distance of closest approach on the 
order of probe molecular diameters predicts that the efficiency of energy transfer 
should be nearly 100% for most of the acceptor loadings used in this study, while 
the experimental FRET data is below 55% energy transfer efficiency for all of the 
acceptor loading s used in this study.  The experimental FRET data was only 
adequately described by Eqn. 6 with the distance of closest approach of 135 
Å(~17 molecular diameters) for the 30°C data and 129 Å(~16 molecular 
diameters) for the 60°C data.  This analysis suggest the presence of laterally phase 
separated domains that are extremely acceptor poor as would be the case for 
immiscible cholesterol domains, and that the domain size is on the order of 270 Å 
in diameter.  Also the action of heating the membranes partially disrupts the 
domain phase as seen by the lower distance of closest approach in the 60°C data 
as compared to the 30°C data. 
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Adapting the energy transfer model (Eqn. 6-9) for lateral phase separation 
gave better fits to the experimental data than random distribution model (Eq. 6), 
thus making lateral phase separation of immiscible cholesterol domains a 
plausible explanation for the low efficiency of energy transfer seen at high 
acceptor loadings seen in the 40-mole% cholesterol FRET data.  At 30°C the best-
fit domain radius is 144 Å with a donor partition coefficient of 50(see Fig. 4.9).  
The assumed value of the donor partition coefficient does not greatly affect the 
value of the determined domain radius, varying from 190 Å to 135 Å as KpD went 
from 10 to 1000, but not all values of KpD adequately described the data, thus 
making the estimated domain radius a weak function of assumed donor partition 
coefficient.   
 
In summary, we provide a novel technique to access the formation of 
immiscible cholesterol domains in membranes in real time.  In our study, artificial 
membrane bilayers were constructed using cholesterol and Egg-PC or DMPC to 
analyze the ability of the membrane probes ERGO and DANSYL to report on the 
formation of cholesterol domains.  The formation of these domains goes beyond 
mere academic curiosity since we have previously shown, using X-Ray 
diffraction techniques that smooth muscle cell membranes isolated from the 
arterial wall are enriched with cholesterol very early in the development of 
atherosclerotic lesions in cholesterol-fed rabbits [27].  In the Chen study, in-vivo 
enrichment of the cell membrane with cholesterol paralleled the increase in serum 
cholesterol levels resulted in a marveled increase in membrane bilayer width(54-
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63 Å, ie 17%!).  We further demonstrated [11] that the membrane demonstrates a 
free cholesterol saturation limit,(~70 mole % in-vivo) beyond which lateral phase 
separation occurs resulting in the formation of immiscible cholesterol domains.  
The impact that these domains have on cell function is not clear, but we suggest 
that they give rise to the formation of the crystalline cholesterol clefts typically 
found in mature atherosclerotic plaques.  The application of ERGO and DANSYL 
fluorescence should permit the analysis of cholesterol nucleation in living cells. 
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Figure 4.1 Energy transfer geometries:  The distance of closest approach for 
membranes without (1) and with (2) domains.  (1)  When no domains are present, 
molecular diffusion allows the donor ERGO (E) and the acceptor DANSYL (D) 
to come within one molecular diameter(a).  (2)  The presence of a domain within 
the bilayer which excludes the acceptor and increases the distance of closest 
approach to the size of the domain radius (n). 
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Figure 4.2 DMPC/Cholesterol experimental phase diagram from reference 
[18].  Filled circles denote the compositions and temperatures used in this study 
(set B).  Along the lines with arrows, temperature was varied in 1°C intervals.  ∆ 
denotes the liqid ordered to liquid disordered phase boundaries as determined 
from piecewise continuous fits of DANSYL emission maxima in this study.  
Redrawn from reference [28]. 
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Figure 4.3 DANSYL emission spectra in Egg-PC MLV as a function of 
increasing cholesterol mole percentage.  In the absence of cholesterol, DANSYL 
exhibits an emission maximum at 515 nm.  The DANSYL emission maximum 
remains fixed until the cholesterol loading 30mole%.  Beyond 30mole% 
cholesterol, the DANSYL emission maximum blue shifts to shorter wavelengths.  
At 65mole% cholesterol, the DANSYL emission maximum has decreased to 
470nm. 
 56
460
470
480
490
500
510
520
530
0 20 40 60 80
Mole % Cholesterol
D
A
N
SY
L 
Em
is
si
on
 M
ax
im
um
 (n
m
)
Intital 28 C
Heated 48 C
Cooled 28 C
I II III
R
ed
 S
hi
ft
R
es
id
ua
l B
lu
e 
S
hi
ft
 
Figure 4.4 DANSYL Response of emission profile to heating in Egg-PC 
MLV.  The data of Fig. 4.3 are re-plotted as the DANSYL emission maximum 
versus cholesterol loading at 28°C(◊).  Also shown is the DANSYL emission 
profile obtained after heating to 48°C( ), and three Zones emerge.  In Zone I, for 
which there is little to no blue shift as a function of cholesterol loading @ 28°C, 
heating produces a small but noticeable increase (i.e. red shift) in the DANSYL 
emission wavelength.  In Zone II, for which the 28°C emission wavelength 
decreases (blue shift) nearly linearly with cholesterol loading, heating produces a 
significant red shift that increases in direct proportion to the cholesterol loading.  
In Zone III, for the blue shift @ 28°C was maximal and did not vary with 
cholesterol, heating had little to no effect.  Nearly identical DANSYL emission 
profiles to these shown here were obtained through three heating and cooling 
cycles.   
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Figure 4.5 DANSY
At 30°C in the absenc
511nm, and the DANS
cholesterol loading is 
Beyond ~20mole% ch
decreases to a value of
samples at 30°C.  At 6
constant at a value of I20 30 40
ole% Cholesterol
 
L Response of emission profile to heating in DMPC MLV.  
e of cholesterol the DANSYL emission maximum occurs at 
YL emission maximum steadily decreases as the 
increased to a value of 509nm at 25mole% cholesterol.  
olesterol the DANSYL emission maximum sharply 
 495 and 485nm in the 35, and 40mole% cholesterol 
0°C the DANSYL emission maximum is approximately 
514nm as a function of cholesterol loading. 
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Figure 4.6 DANSYL emissions maximum as a function of temperature in 
DMPC/cholesterol MLV for 15(a), 20(b),and 25(c)mole% cholesterol.  The 
DANSYL emission maximum at 30ºC occurs at 510, 509, and 509 nanometers for 
the 15, 20, 25mole% samples, respectively.  The DANSYL maximum emission 
wavelength increases linearly with temperature and then remains constant at a 
value of 513nm beginning at 42ºC, 46ºC, and 48ºC for the 15, 20, 25mole% 
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cholesterol samples respectively.  Best fits are shown as solid lines, and the 
temperature yielding the best fits are indicated (dashed lines) as points A,B,C for 
15, 20, and 25 mole percent cholesterol respectively.
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Figure 4.7 Additional Evidence of Cholesterol Domains:  The efficiency of 
energy transfer as a function of acceptor loading (ALR) for the 40mole% 
DMCP/chol sample of set C.  Measured values are shown as (●) and (◊) for the 
30ºC and 60ºC data respectively.  The predictions were calculated via Eqn. 6 
assuming no domains were present, and the only fitted parameter was the distance 
of closet approach.  Obtaining a reasonable fit of the data required a distance of 
closest approach of 110 Å, which is much larger than one molecular diameter 
expected if no domains are present.  Also shown is the measured energy transfer 
profile at 60ºC.  The overall increase in energy transfer efficiency upon heating is 
consistent with Fig. 4.5, and is consistent with the melting or shrinking of 
domains. 
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Figure 4.8 Estimation of Domain Sizes:  the efficiency of energy transfer is 
shown as function of acceptor loading (ALR) for the 40mole percent DMPC/chol 
sample of set B.  Experimentally determined values are shown as filled circles.  
Predicted energy transfer efficiency profiles are shown as solid lines, as calculated 
with equation 6 for varying domain radii.  Also shown is the profile that is 
expected if no domains are present.  The low amount of energy transfer efficiency 
( less than 50%), regardless of the acceptor loading, is strong evidence of domains 
formation and confirms the earlier DANSYL temperature studies.  A best fit of 
the data suggests that the size of the domains is on the order of 220 Å in diameter. 
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Figure 4.9 Effect of the donor partition coeffeicient on the calculated best fit :  
The analysis of Fig. 4.8 was repeated using a wide range of KpD values.  It is seen 
that the key finding of this study, viz. the existence of cholesterol domains is not 
imparted by the value of KpD.  For KpD values ≥ 50, the choice of KpD has no 
effect.  The choice of the KpD value below 50 does impact the results.  However 
the effect is to increase the domain size, which only reinforces the claim that 
domains are present. 
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CHAPTER 5: FRET Simulations 
 
5.1 Introduction 
Immiscible cholesterol domains (ICD) are laterally phase-separated pure 
cholesterol bilayer clusters that are thought to play a role in atherosclerosis [1].  
Experimental evidence for ICD has been reported in rabbit arterial smooth muscle 
membranes by X-Ray diffraction, [2,3] identifying these domains as potential 
precursors to cholesterol crystals that appear in atherosclerotic plaques.  These 
findings suggest that the membrane may be a site of cholesterol nucleation and 
that the nucleation pathway includes a lateral phase separation of cholesterol 
within the membrane.  We recently developed a fluorescence-based assay to study 
nucleation of cholesterol in biological colloids such as biliary vesicles [4,5], and 
low density lipoproteins (unpublished results).  The assay tracks fluorescence 
energy transfer from ergosta-5,7,9(11), 22-tetraen-3β-ol (ERGO) to 1-acyl-2-[12-
[(5-dimethylamino-1-naphthalenesulfonyl)amino]dodecanoyl]-sn-Glycero-3-
phosphocholine (DANSYL), and nucleation is signaled by and alleviation of 
energy transfer as the fluorophores become separated [4,5].  Our assay also 
showed evidence that nucleation of cholesterol proceeds via lateral phase 
separation within the membrane, which may explain the strong catalytic effect of 
vesicles on the time of appearance of macroscopic cholesterol crystals in super 
saturated bile [6].  We recently conducted a fluorescence-based investigation of 
DMPC/cholesterol model membranes using DANSYL-labeled phospholipids, 
which are sensitive to membrane phase behavior, we reported reversible spectral 
 67
DANSYL shifts consistent with the presence of laterally-phase-separated ICD [7].  
To confirm the presence of these domains and estimate their size in 40mole% 
cholesterol DMPC membranes we used Förster resonance energy transfer 
(FRET).  In addition to being a well-established spectroscopic ruler extensively 
used for measuring nanometer distances between physically-linked donors and 
acceptors, [8], FRET has been used to investigate membrane systems that exhibit 
lateral phase separation [9-13].  Whereas the classical application of FRET entails 
a single separation distance between the donor and the acceptor, complexities 
arise in biological membranes.  Specifically, the population of donors transfers 
energy to multiple unlinked acceptors, leading to a distribution of separation 
distances [14-18].  These complications combined with the fact that energy is 
transferred to acceptors in the continuous phase from donors both within domains 
and within the continuous phase, prompted us to make several refinements to the 
classical theory, along with several simplifying assumptions in analyzing our data.   
The purpose of this investigation is to test the ability of our modified 
FRET model to estimate the size of laterally-phase-separated ICD in model 
membranes.  We use a lattice model to simulate membrane bilayers with a 
predetermined uniform size distribution of cholesterol immiscible domains.  We 
then substitute cholesterols and phospholipids with their fluorescent analogs and 
calculate the efficiency of energy transfer as a function of acceptor concentration 
in these lattices.  The simulated efficiency of energy transfer as a function of 
acceptor concentration data is then fitted with the analytical FRET model using 
the domain size as the only fitting parameter.  We assess the adequacy of the 
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model by comparing the best fit domain size to the exact input size.  Finally, to 
test whether the model can also predict partitioning of donors among domains and 
the continuous phase, probes, we include a donor partition coefficient as a second 
fitting parameter and again compare the fitted results with the input values. 
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5.2 Simulations 
Lattice models are well established for studying the lateral distributions of 
membrane components [19,20].  Here we use two vertically-coupled 2-
dimensional square lattices to simulate a section of a membrane bilayer with a 
mono-disperse size distribution of ICD of predetermined sizes.  We then generate 
simulated FRET data analogous to data we obtain experimentally, which consist 
of measures of the efficiency of energy transfer as a function of acceptor 
concentration, for each of four domain size distributions. 
5.2.1 Simulation Details 
The two leaflets of a membrane bilayer are represented by two coupled 
100x100 square lattices, where each lattice site can be occupied by either a 
phospholipid or a cholesterol molecule.  To confirm the adequacy of the 100x100 
lattice, the lattice size was increased to 200x200.  This setup led to a significant 
increase in computational time, while the average efficiency of energy transfer 
remained the same to within 1%.  Although the larger lattice yielded a 50% 
decrease in the standard deviation, the 100x100 size was deemed more suitable 
and more practical.  Moreover, the efficiency of energy transfer is proportional to 
the inverse sixth power of the probe separation distance, and so is effective over a 
distance about five times the Förster distance [14].  As the Förster distance (that is 
the distance at which energy transfer efficiency is 50%) for the ERGO/DANSYL 
FRET pair is 5 nm [21], the 100x100 molecule lattice is 82 nm wide and hence 
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16.4 times the Förster distance, is sufficiently large to capture the full range of 
possible FRET interactions.   
The lattice spacing is determined by the concentration-weighted, average 
diameter of phospholipid (0.94nm) and cholesterol (0.70nm) molecules [22].  
Accordingly, the 40mole% membrane cholesterol concentration used in this study 
leads to a grid spacing of 0.82 nm.  The bilayer thickness is held constant at 4 nm, 
based on experimental determinations of the thickness of DMPC bilayers [22].   
Fig. 5.1 shows a sketch of the phase diagram for DMPC/cholesterol 
membranes, where the cross-hatched area represents our hypothesized extension 
of the well-established phase boundaries in the white area [23].  Because this 
phase diagram is known below 33 mole%, we propose that the transition to ICD 
must occur at a cholesterol concentration greater than that at the liquid 
ordered/liquid disordered phase boundary.  Accordingly, the left hand phase 
boundary is set to 33mole% cholesterol, while the right hand phase boundary is 
set to unity, as dictated by the inverse lever rule and the fact that the ICD are pure 
cholesterol.  The maximum concentration of cholesterol in PC membranes has 
recently been reported to be 66mole%, beyond which macroscopic cholesterol 
monohydrate crystals are detectable [24].  This solubility limit, which is indicated 
by the symbol X’C, is an “apparent limit”.  Indeed, if cholesterol nucleation occurs 
within the membrane as we hypothesize, then the membrane has the capacity to 
retain stable crystallites (detectable by X-Ray diffraction [1], FRET w/ERGO and 
DANSYL [7], and multiphoton imaging [25]) at concentrations lower than the 
macroscopic solubility limit.  That is, ICD constitute an equilibrium phase within 
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the membrane at cholesterol mole fractions less than X’C.  At higher cholesterol 
mole fractions the ICD exceed a critical size, leading to the macroscopic 
precipitation of cholesterol from the membrane.  The overall sterol mole fraction 
concentration (both ERGO and cholesterol) in these simulations is set at 0.40.  
With the total number of molecules in the simulation fixed by the lattice size and 
the overall sterol concentration specified, the amounts of each phase is determined 
by the inverse lever rule.   
After square domains of a fixed size are randomly placed on the lattice with 
periodic boundary conditions, phospholipid and cholesterol molecules are 
randomly placed on the lattices according to their mole fractions in each phase.  
Unlike the continuous phase, for which the lipid distribution in each leaflet is 
independent, the cholesterol domains span the bilayers and are thus symmetric.  
With the lateral distributions of phases and lipids specified, the next step is to 
incorporate the fluorescent probes into the simulations.  This corresponds to the 
experimental use of the cholesterol analog donor ERGO and the phospholipid 
analog acceptor DANSYL.  The mole fraction of donors is held constant at 0.01, 
while the acceptor mole fraction is varied from 0 to 0.05 to mimic FRET 
experiments.  Based on the specified donor mole fraction and a partition 
coefficient (defined below), cholesterols in each phase are then randomly selected 
and replaced by FRET donors.  The same process is carried out for the 
substitution of phospholipids for acceptor molecules.  In the present study, the 
discrete phase is (ICD) pure cholesterol so specification of an acceptor partition 
coefficient is not needed.  Fig. 5.2 shows typical ICD configurations for four 
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sample simulated membranes containing a total cholesterol mole fraction of 0.40 
(only top leaflet shown).  Ten such configurations were generated for each mole 
fraction, and simulation results reported herein are the averages of the multiple 
configurations.  Phospholipids are depicted in dark blue, cholesterols in light blue, 
donors in yellow, and acceptors in red.  The domains shown have hydrodynamic 
diameters of 27.1 nm (a), 15.6 nm (b), 9.86 nm (c), and 4.96 nm (d).  These sizes 
correspond to approximately 5, 3, 2, and 1 times the Förster distance of the 
EGRO/DANSYL FRET pair, respectively.   
Table 1 lists input parameters used in each simulation performed in this 
study.  D is the domain diameter in nm, the donor to lipid ratio (DLR) is the donor 
mole fraction, the acceptor to lipid ratio (ALR) is the acceptor mole fraction, and 
KpD is the donor partition coefficient given by the ratio of the mole fraction of 
donors in the ICD phase to the continuous phase.   
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5.2.2 Calculation of Simulated Energy Transfer Efficiency Data 
A coordinate system is defined and the distance between every donor and 
acceptor is calculated assuming periodic boundary conditions.  We impose an 
interaction cutoff of 25 nm (beyond which interactions are negligible) for donors 
in the lattice to acceptors in the periodic regions.  The fluorescence decay function 
for a single donor, j, in the presence of multiple acceptors at various distances, 
ρjDA(t) is given by: 
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where τ0 is the fluorescence lifetime of the unquenched donor, NA is the total 
number of acceptors, R0 is the Förster distance, Rjk is the distance between donor j 
and acceptor, k, and t is time [9].  The average donor decay function IDA(t) in the 
presence of acceptors is then: 
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where ND is the number of donors.  The fluorescence decay function for a donor 
in the absence of acceptors ID(t) is modeled as a single exponential decay.   
 
 74
dtttI D ⋅τ−= )/exp()( 0        (3) 
After the decay functions are calculated from the known probe distributions in the 
membrane lattices, the efficiency of energy transfer is calculated by numerically 
integrating the decay functions according to: 
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Using Eqs. (1)-(4), it is possible to calculate the efficiency of energy transfer in 
systems of unlimited complexity so long as the spatial locations of all donors and 
acceptors are known (as they are in these simulations).  As these exact locations 
cannot be determined in experimental FRET studies of unlinked donors and 
acceptors in membranes, analytical FRET models become necessary to interpret 
experimental data. 
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Table 5.1 Summary of simulation input parameters.  D is the known domain 
diameter, DLR is the donor mole fraction, ALR is the acceptor mole fraction, and 
KpD is the donor partition coefficient.    
 
Simulation D (nm) DLR x103 ALR x103 KpD  
A1 4.93 1 1,2,5,10,20,30,40,50 1 
A2 4.93 1 1,2,5,10,20,30,40,50 50 
A3 4.93 1 1,2,5,10,20,30,40,50 200 
B1 9.86 1 1,2,5,10,20,30,40,50 1 
B2 9.86 1 1,2,5,10,20,30,40,50 50 
B3 9.86 1 1,2,5,10,20,30,40,50 200 
C1 15.6 1 1,2,5,10,20,30,40,50 1 
C2 15.6 1 1,2,5,10,20,30,40,50 5 
C3 15.6 1 1,2,5,10,20,30,40,50 10 
C4 15.6 1 1,2,5,10,20,30,40,50 25 
C5 15.6 1 1,2,5,10,20,30,40,50 50 
C6 15.6 1 1,2,5,10,20,30,40,50 200 
D1 27.1 1 1,2,5,10,20,30,40,50 1 
D2 27.1 1 1,2,5,10,20,30,40,50 50 
D3 27.1 1 1,2,5,10,20,30,40,50 200 
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5.2.3 Analytical Modeling of Simulated FRET Data 
We have previously described a theory accounting for lateral phase 
separation of cholesterol-rich domains in membranes [7].  Briefly, that work made 
four simplifying assumptions: 1) donors are at the center of domains 2) acceptors 
are completely excluded from the domains, 3) the shape of the domains is disk-
like, and 4) the domains are symmetric along the plane of the bilayer [7].  Energy 
transfer occurs in two ways: 1) from donors in the center of discrete domains to 
acceptors in the continuous phase and 2) from donors in the continuous phase to 
acceptors in the continuous phase.  The efficiency of energy transfer is calculated 
for one donor in each environment, and the overall efficiency of energy transfer is 
calculated as the weighted average of the efficiency of energy transfer in each 
environment, based on the relative fractions of donors in each phase.  The 
formulation is described mathematically by Eq. (5), where τ0 is the fluorescence 
lifetime of the unquenched donor, t is time, r is distance, and R0 is the Förster 
distance.   
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The acceptor surface density (σ), which is the concentration of acceptors per unit 
area of membrane, is related to ALR by the following expression, where Ac is the 
average cross sectional area of a lipid molecule [26]. 
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σ=ALR/(Ac)   (6) 
 
The two lower limits of integration used in Eq. 5 (LL1 and LL2) correspond to the 
distance of closest approach (DCA) between donor and acceptor.  The values of 
LL1 and LL2 depend on the type of phase in which the energy transfer takes place.  
In the continuous phase, migration of the fluorophores is unrestricted, and the 
DCA is approximately the average molecular diameter, a, of the donor and 
acceptor (so LL1=a) within a leaflet.  Also, acceptors can reside directly beneath 
a donor so that LL2 is given by the bilayer thickness h.  On the other hand, 
domains exclude acceptors so that the DCA equals the domain radius, n (LL1=n) 
and across the leaflet is given by LL2=(n2+h2)1/2.  Fig. 5.3 shows a schematic of 
the energy transfer geometries for donors in each environment.  
 
Given this description of E in each phase, we now need to estimate the relative 
amounts of donors and acceptors in each phase.  By a material balance, the 
relative amount of donor in the continuous phase is:  
 
)/( CCDDCC XXKpKpX +⋅−=φ       (7) 
where XC is the mole fraction of lipids in the continuous phase and KpD is the 
donor partition coefficient. (KpD = xD2/xD1, where xD2 and xD1 are the mole 
fractions of donors in the domain phase and continuous phase respectively) 
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The predicted efficiency of energy transfer (EPRED) is then a weighted average of 
the energy transfer in the continuous (EC) and discrete (ED) phases.   
 
DCCCPRED EEE ⋅−+⋅= )1( φφ       (8) 
 
We will now test the efficiencies of energy transfer predicted by Eqs. (5)-(8) with 
the simulated FRET data from the known distributions in the lattice model from 
Eqs. (1)-(4).   
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5.3 Results 
5.3.1 Simulations of Known Distributions 
To explore the effects of the size of laterally phase separated cholesterol 
immiscible domains on the efficiency of energy transfer between a cholesterol 
analog donor and a lipid analog acceptor, a lattice simulation of DMPC-
cholesterol membranes was used to generate predetermined size distributions of 
ICD.  FRET experiments were mimicked by holding the donor mole fraction 
constant and varying acceptor concentration in 40mole% cholesterol DMPC 
lattice model membranes with mono disperse immiscible cholesterol domains 
whose hydrodynamic diameters were 4.96 nm, 9.86 nm, 15.6 nm, and 27.1 nm.  
Eqs. (1)-(4) were then used to calculate the exact efficiency of energy transfer.  
The effect of the donor partition coefficient on the energy transfer efficiency as a 
function of acceptor loading profiles was studied by varying the amount of donors 
in each phase to correspond to donor partition coefficient values of 1, 50, and 200.  
Fig. 5.4 shows the simulated efficiency of energy transfer as a function of ALR 
for each of the four domain size using three donor partition coefficients (a) 
KpD=1, (b) KpD=50, and (c) KpD=200.  For KpD=1 (simulations A1, B1, C1, and 
D1), shown in Fig. 5.4a, the energy transfer efficiency increases by approximately 
90% from ALR=0 to ALR=0.02, and remains constant or increases slightly above 
ALR=0.02, regardless of the domain size.  The energy transfer efficiencies at 
ALR=0.05 are 97.0, 96.7, 95.8, and 93.6 percent for membranes A1, B1, C1, and 
D1 respectively.  Increasing the domain size from 4.93 nm to 27.1 nm only 
changes the efficiency of energy transfer at ALR=0.05 by 3.5%.  Fig. 5.4b 
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(simulations A2, B2, C5, and D2) shows that the FRET profiles are strongly 
dependent on the domain size at KpD=50.  Specifically, the efficiencies of energy 
transfer at ALR=0.05 are 96.4, 92.3, 81.4, and 61.5 percent for membranes A2, 
B3, C5, and D2 respectively.  Fig. 5.4c (simulations A3, B3, C6, and D3) shows a 
similar dependence on domain size when KpD=200.  The efficiencies of energy 
transfer at ALR=0.05 are 96.2, 91.9, 81.9, and 60.0 percent for membranes A3, 
B3, C6, and D3, respectively.  The difference between the KpD=50 and KpD=200 
data is approximately 12%. 
Fig. 5.5 shows the sensitivity of energy transfer efficiency to the donor 
partition coefficient.  Shown is percent energy transfer versus acceptor to lipid 
ratio for six values of KpD in a simulated membrane with ICD that are 15.6 nm in 
diameter. (1(C1), 5(C2), 10(C3), 25(C4), 50(C5), and 200(C6))  Increasing KpD 
systematically lowers the efficiency of energy transfer.   
5.3.2 Model Predictions and Comparison with Simulation Results 
To test the ability of the analytical FRET model to fit actual FRET data, 
with the purpose of estimating domain sizes, the predictions of Eqs. (5)-(8) are 
compared with the simulation results (i.e. Eqs (1)-(4) applied to known 
distributions from the lattice model). All of the simulated FRET data sets in Table 
1 were fit with Eqs. (5)-(8) by minimizing the sum of the squared errors (SSQE).  
The lower limits of integration (LL1 and LL2) in the continuous phase were fixed 
at 0.82 nm (average molecular diameter) and 4 nm (bilayer thickness).  The donor 
partition coefficients were set to the input values, thus the only parameter left 
open to the fit is the domain radius, n, which appears in the lower limits of 
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integration in the domain phase.  The ’best fit’ domain diameters (d=2n) along 
with their corresponding SSQE and percent error values are shown in Table 2.  
Fig. 5.6 shows the simulated data for the membrane with 27.1 nm diameter 
domains at KpD=1, KpD=50, and KpD=200 (simulations D1, D2, and D3).  Solid 
lines are the best fits of the analytical FRET model, which yielded domain 
diameters of 12.0, 12.8, and 13.0 nm for KpD=1, 50, and 200, respectively.   
To test the ability of the FRET model to predict the donor partition coefficient in 
addition to the domain size, the lattice model FRET data with domains of known 
diameter (15.6 nm) and known partition coefficient (KpD=25) (simulation C4), 
were fit with Eqs. (5)-(8) in the usual fashion, leaving the domain radius open to 
the fit.  However, the fitting process was repeated using five different values of 
KpD , and Fig. 5.7 displays the best fit domain size as a function of these assumed 
KpD values.  The estimated domain size is a strong function of the assumed donor 
partition coefficient in the range (KpD=1-5), but this dependence is much weaker 
for KpD >=10.  Table 3 shows the values of the estimated domain diameter and 
the SSQE for the assumed KpD values:1, 5, 10, 25, 200.  Note that the best 
estimate of the actual domain size occurs when KpD=5, but the best numerical 
description of the simulation C4 data that is, lowest SSQE=17.5 is obtained with 
an assumed KpD=25.  This is a general result; namely the best fit accurately 
reports the value of KpD while underestimating the actual domain size.  The C4 
data is shown here merely as an example.   
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Table 5.2 Comparison of the domain diameter estimated from fitting the 
analytical FRET model (the diameter estimated using Eqs. (5)-(8), d) to the exact 
simulated lattice FRET data (D). We also report the sum of the squared errors 
(SSQE) and the percent error for each simulation. 
 input input Output   
Simulation KpD D(nm) d(nm) SSQE %error 
A1 1 4.93 5 14.1 1.42 
A2 50 4.93 4.6 11.3 -6.69 
A3 200 4.93 4.6 7.7 -6.69 
B1 1 9.86 7.4 9.1 -24.9 
B2 50 9.86 7.4 12.7 -24.9 
B3 200 9.86 7.2 13.8 -27.0 
C1 1 15.6 8.6 21.6 -44.9 
C2 5 15.6 9.4 22.6 -39.7 
C3 10 15.6 11.4 12.0 -26.9 
C4 25 15.6 9.2 17.5 -41.0 
C5 50 15.6 9.4 37.5 -39.7 
C6 200 15.6 9.6 20.7 -38.5 
D1 1 27.1 12 36.3 -55.7 
D2 50 27.1 12.8 63.9 -52.8 
D3 200 27.1 13 114.7 -52.0 
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Table 5.3 Best fit domain diameters and the SSQE for simulation C4 FRET data 
(known KpD =25 and known domain dimeter=15.6 nm) as a function of the 
assumed donor partition coefficient.    
KpD d(nm) SSQE 
1 62 985
5 13.4 97.9
10 10.8 29.5
25 9.2 17.5
50 8 94.8
200 8.2 26.2
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5.4 Discussion 
Membrane bilayers were simulated as coupled two-dimensional lattices 
with total cholesterol fractions of 40 mole percent, and immiscible cholesterol 
domains of diameters ranging from 4.96 nm to 27.1 nm were inserted.  
Fluorescence resonance energy transfer experiments using a cholesterol analog 
donor and a phospholipid analog acceptor were simulated by introducing these 
analogs into the lattice according to their respective partition coefficient in each 
phase.  Plots of the exact efficiency of energy transfer (average of 10 simulations) 
as a function of acceptor concentration were generated for four membrane 
configurations.  The simulated data sets were then fit with an analytical FRET 
model that predicts energy transfer efficiency and is used to estimate domain size 
from experimental data analogous to that generated by the lattice model.  
Simulations were preformed at a constant domain size with increasing values of 
the donor partition coefficient to quantify the effects of preferential probe 
separation on the efficiency of energy transfer.   
 
5.4.1 Effect of Domain Size and Donor Partition Coefficient 
As the size of the laterally phase-separated domains increases, the 
efficiency of energy transfer is systematically lowered.  This is due to the fact that 
the acceptors are completely excluded from the domains, which leads to an 
increased separation distance and thus a lowered energy transfer efficiency.  
However, the sensitivity to size depends on the donor partition coefficient.  When 
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the donor partition coefficient is unity, the effect of increasing the domain size is 
small because energy transfer in the continuous phases dominates.  As the value 
of KpD increases, the contribution to the overall energy transfer from donors in 
domains also increases.  By material balance, one recognizes that at values of KpD 
> 8.3, more donors are in the domains than in the continuous phase. Accordingly, 
energy transfer from donors in the domains dominates at KpD values greater that 
10, and increases in KpD beyond 50 exhibit little effect (Figs. 5.5 and 5.7).  It 
should be appreciated that the large domain sizes and donor partition coefficients 
act synergistically.  Any donor in a domain larger than 5xR0 will be unable to 
participate in energy transfer, and the number of donors affected depends on KpD.   
5.4.2 Analytical Model Evaluation 
The analytical FRET model is able to estimate the size of immiscible 
cholesterol domains fairly well for the simulated membranes with 4.93 nm and 
9.86 nm diameter domains.  The respective percent errors in the size estimation 
are approximately 7% and 25%, regardless of the donor partition coefficient used 
to generate the simulated FRET data.  When estimating the size of 15.6 nm and 
27.1 nm domains, the errors were 40% and 55%, respectively.  This increased 
error is due to the fact that FRET is most sensitive for determining length scales 
that are near the Förster distance, and ineffective for length scales larger than five 
times the Förster distance.  Therefore, while FRET can be used to test for the 
presence of lateral phase separations, the determination of the size of the domains 
is limited to domains smaller than 25 nm for the ERGO/DANSYL pair.  Another 
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limitation arises from the assumption that the donors are located in the center of 
the domains, which leads to systematic under-predictions of the size of the ICD. 
We have recently used this FRET model to estimate the size of immiscible 
cholesterol domains in 40mole% cholesterol DMPC membranes to between 10 
nm and 20 nm [7].  In that work the measured FRET efficiencies were less than 
50%, even at the highest acceptor loadings.  Here, the limiting FRET efficiency is 
determined by simulation to be approximately 60% (27.1 nm domains, 
ALR=0.05).  This disagreement potentially means that the distance of closest 
approach of ERGO and DANSYL in the continuous phase is greater than one 
molecular diameter, as is implicitly the case in our lattice model simulations.  
Regardless, the present study validates the use of our analytical model in 
determining the domain sizes used in our experimental system, as these sizes (10 
nm-20 nm) fall within the range of FRET sensitivity of the ERGO/DANSYL 
FRET pair, and suggests that the error associated with our size estimation is 
approximately 40%-50%. 
In addition, we show that the FRET model can also be used to estimate the 
donor partition coefficient.  If the donor partition coefficient is not known it can 
be left open in the fit.  Fig. 5.7 shows the best-fit domain size from the domain 
model for increasing values of KpD, and Table 3 shows the SSQE for assumed 
KpD.  It is evident from Fig. 5.7 that best fit domain size is a weak function of the 
assumed partition coefficient for values of KpD >=10.  The lowest SSQE in Table 
3 corresponds to KpD=25, the value that was used to generate the data, which 
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justifies leaving both the domain size and KpD as free parameters in the fitting of 
experimental data where neither is known.   
We expect that the domain model and FRET methodology described in 
this work can be extended to the analysis of other systems that display lateral 
phase separation.  The first requirement for these applications is that acceptors 
must be excluded from the discrete phase.  Secondly, reliable size estimates are 
subject to the limitations imposed by the Förster distance, making this technique 
best-suited for studying the initial birth or nucleation of a discrete phase whose 
domain sizes are expected to range between 1nm and 25 nm.   
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Figure 5.1 Hypothetical phase diagram for DMPC/cholesterol membranes.  
The hatched section shows our hypothetical extension of the established phase 
diagram in the white area.  This study focuses on the two-phase region where 
immiscible cholesterol domains coexist with the liquid ordered phase.  The 
dashed line is the cholesterol concentration (X`C) above which macroscopic 
cholesterol crystals can be detected.  LD is the liquid disordered phase, LO is the 
liquid ordered phase, SO is the solid ordered phase, and ICD is the immiscible 
cholesterol domain phase.   
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Figure 5.2 Examples of typical mono-disperse domain and probe configurations for a 
DMPC-cholesterol bilayer containing 40mole% cholesterol, as simulated in the lattice 
model.  Phospholipid is shown in dark blue, cholesterol in light blue, donors in yellow, 
and acceptors in red.  Because the domains span the bilayers, only the top leaflet is 
shown.  The cholesterol concentrations in the continuous phase are 33mole% and the 
discrete phase is pure cholesterol.  The hydrodynamic diameters of the domains are (top 
left) 27.1 nm, (bottom left) 15.6 nm, (top right) 9.86 nm, and, (bottom right) 4.96 nm.  
KpD=1, DLR=0.01, and ALR=0.02.   
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Figure 5.3 Energy transfer geometries: the distance of closest approach is 
depicted for membranes (1) without and (2) with domains.   
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Figure 5.4 Percent efficiency of energy transfer versus acceptor to lipid ratio 
for (a) KpD=1, (b) KpD=50, and (c) KpD=200 for simulated membrane bilayers 
with immiscible cholesterol domains.  Domains have the following sizes:4.93 
nm(∗), 9.86 nm(∆), 15.6 nm(□) and 27.1 nm(♦) in diameter. 
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Figure 5.5 Effect of donor partition coefficient on the efficiency of energy 
transfer in a 40mole% cholesterol DMPC lattice model membrane with 15.6nm 
immiscible cholesterol domains.  (◊) KpD=1, (∆) KpD=5, (×) KpD=10, (ο) 
KpD=25, (□) KpD=50, (+) KpD=200. 
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Figure 5.6 Simulated efficiency of energy transfer data for membrane 
containing 27.1 nm diameter domains.  (□) KpD=1, (ο) KpD=50, (∆) KpD=200.  
The solid lines are the best fits of the simulated data with equations (5)-(8). 
 94
 
0
10
20
30
40
50
60
70
0 25 50 75 100 125 150 175 200
Kp D
D
om
ai
n 
D
ia
m
et
er
 (n
m
)
*
 
Figure 5.7 Best fit domain diameters as a function the assumed donor 
partition coefficient for a simulated membrane with 15.6 nm diameter domains 
and KpD set to 25.(simulation C4)  The best fit domain diameter is a weak 
function of the assumed partition coefficient for KpD>10.  The point * reflects the 
known diameter and partition coefficient.  Whereas the best estimate of the 
domain size occurs with assumed KpD=5, the best fit (i.e. lowest SSQE) occurs 
with an assumed KpD=25. Thus the analytical FRET model reports the exact KpD  
value while underestimating the domain size. 
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CHAPTER 6: DANSYL TRES Studies 
 
6.1 Introduction 
The effect of cholesterol on the properties of model membranes has been 
an area of intense investigation because of the role cholesterol plays in human 
disease.  Model membrane systems are important because they serve as platforms 
for the systematic study of cholesterol-related-diseases such as atherosclerosis and 
gallstone pathogenesis.  Currently, cholesterol-rich, laterally phase-separated, 
liquid-ordered domains in model membrane systems are under investigation 
because they serve as a model for rafts in natural membranes [1].  In natural 
membranes, rafts are hypothesized to be involved in signal transduction, protein 
stabilization, protein and lipid sorting, and membrane fusion [2].  Additionally a 
laterally phase-separated, cholesterol-only phase termed “immiscible cholesterol 
domains” has been reported to exist in natural and model membranes [3].  This 
finding of pure cholesterol domains suggests that cholesterol-induced laterally, 
phase separated domains might be involved in the nucleation mechanism of 
cholesterol from phospholipid bilayers, possibly serving as pre-nuclei for 
macroscopic cholesterol crystals.   
Fluorescence spectroscopy is capable of studying the dynamics of 
fluorescent molecules and their local environments on the nanosecond time scale 
[4], and therefore has found application in the investigation of phospholipid-
cholesterol mixtures.  In particular, the membrane probe 1-myristoyl-2-[12-[(5-
dimethylamino-1-naphthalenesulfonyl)amino]dodecanoyl]-sn-Glycero-3-
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phosphocholine (DANSYL) and related probes have been used in membrane 
studies because of their sensitivity to solvent polarity [5-7], as well as in 
numerous studies as both a Förster energy transfer donor [8,9] and acceptor [6,10-
13].  The DANSYL fluorophore has been shown to give blue-shifted emission 
spectra in non-polar solvents such as chloroform and toluene and red-shifted 
emission spectra in polar solvents such as ethanol and methanol [14].  We have 
previously shown that the temperature dependence of the polarity-induced 
DANSYL steady-state spectral shifts can be used to determine the liquid-ordered 
(lo) to liquid-disordered (ld) phase transition boundaries in model lipid membranes 
[6].  There we extrapolated the successful analysis of DANSYL steady-state 
spectral shifts in determining known membrane phase behavior (lo and ld phase 
boundaries in DMPC-cholesterol MLV) to detect the presence of laterally phase-
separated cholesterol-rich domains in DMPC MLV at high cholesterol loadings 
(Xchol > 0.30) [6,15].   
Here we perform a steady-state and time-resolved emission spectra study 
of the fluorescent properties of tail-labeled DANSYL DMPC in DMPC MLV 
prepared by modified rapid solvent exchange [16,17] as a function of cholesterol 
concentration at 30°C and 60°C.  We are interested in determining the physical 
mechanism behind the DANSYL spectral sensitivity to cholesterol and membrane 
phase behavior in model membranes.  Specifically, we seek to identify the causes 
of the large spectral shifts in the DANSYL steady-state emission spectra at high 
cholesterol loadings, and the effects of cholesterol on the DANSYL membrane 
penetration depth in DMPC MLV.  Finally, we use our current findings to 
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examine critically our previous results on the use of DANSYL for the detection of 
cholesterol-rich laterally phase-separated domains in model membranes.  The 
results herein suggest that the DANSYL sensitivity to cholesterol is due to 
complex time-dependent solvent effects and identify two separate DANSYL 
populations in DMPC-cholesterol mixtures with cholesterol mole fractions above 
0.30.  We also find that the DANSYL membrane penetration depth in DMPC 
MLV is dependent on cholesterol composition and temperature.   
6.2 Background 
Shifts in fluorescence spectra sometimes arise from solvent effects.  For 
example, the well-known Stokes shift results from the energy lost in the excited 
state due to collisions with solvent molecules.  Solvents effects can be classified 
into three categories: general solvent effects, specific solvent effects, and specific 
probe effects.  General solvent effects are attributable to energy loss due to 
solvent reorganization around the excited state dipole of the fluorophore, which is 
typically complete prior to fluorescence emission.  This is the case for many non-
viscous solvents where the time scale for solvent relaxation is on the order of 10-10 
sec.  In relatively more viscous environments, such as phospholipid membranes, 
the time scale of spectral relaxation can be comparable to the time scale of 
fluorescence emission (10-8-10-9 sec), and the time dependence of spectral 
relaxation can affect the steady-state spectral shifts.  In this case, fluorescence 
emission can occur simultaneously from un-relaxed, partially relaxed, and 
completely relaxed states.  Specific solvent effects are the result of chemical 
bonds between the fluorophore and the solvent.  For example hydrogen bonding is 
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a specific solvent effect that stabilizes the excited state prior to solvent relaxation 
and fluorescence emission, resulting in lower energy fluorescence emission.  
Specific probe effects are inherent to a fluorophore and are characterized by a 
conformational change in the fluorophore molecular structure.  Examples of 
specific probe effects are the formation of an internal charge transfer (ICT) state 
and the formation of a twisted internal charge transfer (TICT) state.  Fluorophores 
possessing both electron donating and electron accepting groups can form ICT 
states in polar environments during the excited state lifetime of the probe.  As the 
name implies, a TICT state is an ICT state that also includes the physical 
rearrangement of functional groups on the probe.  Both ICT and TICT states are 
low energy states and result in lower energy fluorescence emission.   
Time-dependent solvent relaxation, specific solvent effects, and specific 
probe effects in steady-state fluorescence spectroscopy are typically studied with 
time-resolved emission spectroscopy (TRES) [4].  TRES is fundamentally 
different from steady-state fluorescence emission spectroscopy in that the 
excitation source is modified in either the time or the frequency domain.  In 
addition, the fluorescence intensity can be measured as a function of both 
emission wavelength and time during the decay from the excited state to the 
ground state.  The ability of TRES to measure the decay of fluorescence emission 
on the nanosecond time-scale has lead to its widespread use for the study of time-
dependent solvent relaxation as well as specific solvent and probe effects [18-20].  
Two simplified models for time-dependent solvent effects are the continuous 
model and the two-state model.  The continuous model analysis of TRES is 
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characterized by spectra of constant shape shifting in wavelength space as a 
function of time.  Therefore, the continuous model is used to describe time-
dependent dipolar relaxation [20].  The two-state model analysis of TRES 
describes the rise and fall of a locally excited state and a relaxed state as a 
function of time.  The locally excited state and the relaxed state appear as two 
separate peaks in wavelength space; initially only the locally excited state is 
observed, and at long times the relaxed state rises and decays.  Consequently, the 
two-state model has found use in the detection of specific solvent and specific 
probe effects [20]. 
6.3 Materials and Methods 
6.3.1 Chemicals 
DMPC, Cholesterol, CoCl2, NaCl, HEPES, NaN3, and CaCl2, were 
purchases from Sigma Chemical Co. (Sigma-Aldrich, St. Louis, MO).  DANSYL, 
5-DOXYL-PC, and 16-DOXYL-PC were purchased from Avanti Polar Lipds, 
Inc. (Alabaster, AL).  All chemicals were used without further purification.  The 
structures of DANSYL, 5-DOXYL-PC, and 16-DOXYL-PC are shown in Fig. 
6.1.  
6.3.2 Preparation of Multi-lamellar Vesicles (MLV) 
Multi-lamellar vesicles were prepared by the method of modified rapid 
solvent exchange.  [16,17]  Briefly, DMPC, cholesterol, DANSYL, 5-DOXYL-
PC, and 16-DOXYL-PC were dissolved in chloroform to form stock solutions.  
Appropriate amounts of these stock solutions were mixed to give the desired 
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compositions, and this mixture was added to 3 mL of aqueous buffer that was 
preheated to 60°C in a 30 mL flat bottom vial.  The mixture was then vortexed 
and exposed to a vacuum of 25 inches of Hg for 5 minutes.  Hot air (200°F) is 
blown on the vial to minimize evaporative cooling during solvent removal.  An 
additional 7 mL of 60°C aqueous buffer is then added, and the samples are stored 
at room temperature for 24 hrs before use.  The maximum solvent volume is 
always less than 300 µL.  The buffer used in this work contains 0.15 M NaCl, 5 
mM CaCl2, 5 mM HEPES, and 0.02 wt% NaN3, pH 7.4.  The total lipid 
concentration of the resulting membrane suspensions is in all cases 0.65 mM.   
6.3.3 Fluorescence Measurements 
All steady-state fluorescence measurements were made on a Photon 
Technology International Inc. model A-710 with the bandpass set to 2 nm.  The 
excitation wavelength was 337 nm, and the fluorescence emission was measured 
in one nm intervals from 357 nm to 657 nm for all tests.  All steady-state 
fluorescence spectra are uncorrected for the color shift inherent in the detection 
system.  All time-resolved fluorescence measurements were recorded on a Photon 
Technology International model C-71(time domain, stroboscopic system).  The 
excitation source was a pulsed nitrogen laser operating at 337 nm with a 
frequency of 10 Hz and a band pass of 10 nm.  The temperature of the sample 
chamber was controlled to ±0.5°C via a circulating water bath, and the 
temperature was monitored with a cuvette thermometer (Fisher Corp., 
Philadelphia, PA. model # 15-078J).   
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6.3.4 Steady-state DANSYL Temperature Studies 
To determine the effects of cholesterol composition and temperature on 
the DANSYL photo physics, DANSYL was incorporated into DMPC-cholesterol 
mixtures with the following cholesterol mole fractions: 0, 0.05, 0.10, 0.15, 0.20, 
0.25, 0.30, 0.35, 0.40, 0.45, 0.50, 0.55, and 0.60.  The DANSYL mole fraction in 
all the mixtures is 0.01.  The steady state emission spectra and excitation spectra 
were recorded at both 30°C and 60°C for all the samples.  Excitation spectra were 
recorded at emission wavelengths of 550 nm and 450 nm.  The excitation was 
varied in 1 nm intervals from 280 nm to 425 nm and from 230 nm to 300 nm for 
the 550 nm and 450 nm emission wavelengths respectively.   
6.3.5 Cobalt Quenching Water Penetration Studies 
To determine the effect of cholesterol composition and temperature on 
water penetration into the membrane, 10 mM of CoCl2 was incorporated in the 
aqueous buffer, and the pH was adjusted to 7.4.  This CoCl2 concentration was 
selected as it is sufficiently high to give efficient quenching and sufficiently low 
to ensure solubility in the aqueous buffer at pH=7.4.  DMPC-cholesterol mixtures 
(in the buffer containing 10 mM CoCl2) at the following cholesterol mole 
fractions were prepared: 0, 0.05, 0.10, 0.15, 0.20, 0.25, 0.30, 0.35, 0.40, 0.45, 
0.50, 0.55, and 0.60.  The steady-state emission spectra for this sample set were 
recorded at 30°C.   
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6.3.6 Nitroxide Quenching DANSYL Depth Studies 
To estimate the membrane penetration depth of DANSYL, 0.10 mole 
fractions of 5-DOXYL-PC and 16-DOXYL-PC were incorporated separately in to 
DMPC-cholesterol mixtures with the following cholesterol mole fractions: 0, 
0.05, 0.10, 0.15, 0.20, 0.25, 0.30, 0.35, 0.40, 0.45, 0.50, 0.55, and 0.60.  The 
steady-state emission spectra and excitation spectra were recorded at both 30°C 
and 60°C.   
6.3.7 Time-resolved Emission Spectra (TRES) Measurements 
To maximize wavelength resolution, apparent TRES were recorded 
directly utilizing a time domain stroboscopic detection system.  The TRES 
presented in this work are apparent TRES, meaning that the measured 
fluorescence intensity data has not been corrected for two effects, 1) the color 
shift introduced by the detection system and 2) convolution with the excitation 
pulse.  Recognizing that these two effects are present the data will be interpreted 
in terms of relative changes and not as absolute values.  The convolution effect is 
expected to decrease the resolution of the TRES somewhat, but we will show that 
the physics controlling the spectral shifting are significant enough to be readily 
detectable.  The fluorescence intensity was measured in 2 nm intervals between 
357 nm and 657 nm at delay times of 38, 39, 41, 44, 49, 59, 79, and 99 ns.  These 
delay times correspond to approximately 0, 1, 3, 6, 11, 21, 41, and 61 ns after the 
excitation pulse.  Time zero is defined as the leading edge of the measured 
response function.  The reported data at each wavelength are the average of 
fifteen separate excitation pulses.    
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6.3.8 Analysis of Experimental Data 
All DANSYL spectra were smoothed and normalized [21].  As the 
DANSYL fluorescence emission and excitation spectra are highly unstructured, 
we employ the spectral center of gravity (SCG) and the spectral half width (SHW) 
as defined by Eqs. 1 and 2 to characterize the spectra.   
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The rate of spectral relaxation is quantified by tracking the SCG as a 
function of time after the excitation pulse, SCG(t).  SCG(t) is calculated according 
to Eq. 1 for each delay time after the excitation pulse, where FI(λ) is the number 
of photons per nanometer interval.  Changes in spectral shape as a function of 
time are quantified by tracking the SHW as a function of time after the excitation 
pulse, SHW(t) is calculated with Eq. 2 for each delay time.   
The time course of the SCG can be fit by the method of non-linear least squares to 
extract the spectral relaxation times according to the following equation.   
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Where SCG∞ is the SCG at infinite time, SCG0 is the initial SCG when t equals 
zero, t is time, β1 and β2 are exponential pre-factors, and τr1 and τr2 are the 
spectral relaxation times.  Finally, the mean relaxation time, 〈τSR〉, is given by 
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The DANSYL fluorescence quenching induced by the aqueous Cobalt and 
the site-specific n-DOXYL-PC quenchers are quantified by the quenching ratio, 
RQ, defined by Eq. 5, where FI(550nm) is the quenched fluorescence intensity at 
550 nm, and FI0(550nm) is the unquenched fluorescence intensity at 550 nm.   
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The depths of the DANSYL probe in the membrane are estimated using 
parallax analysis, and are calculated using Eq. 6, where Zcf is the distance of the 
probe from the center of the bilayer, Lc1 is the distance of the shallow quencher to 
the bilayer center, F1 is the fluorescence intensity of the probe in the presence of 
the shallow quencher, F2 is the fluorescence intensity of the probe in the presence 
of the deep quencher, C is the quencher concentration in number of molecules per 
unit area, and L21 is the distance between the shallow and deep quenchers [22]. 
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6.4 Results 
6.4.1 Steady-state Fluorescence Characterization of DANSYL in DMPC-
Cholesterol MLV 
 
To demonstrate the effects of cholesterol on steady-state fluorescence 
spectral properties of DANSYL in DMPC MLV we measured the DANSYL 
steady-state emission spectra and the steady-state excitation spectra as a function 
of cholesterol loading at both 30°C and 60°C.  The DANSYL fluorescence 
emission and excitation spectra are highly unstructured, meaning that they display 
no distinct vibrational structure and so yield a single broad peak.  Therefore, the 
DANSYL fluorescence spectra lend themselves readily to analysis with the SCG 
and SHW as defined by Eq. 1 and Eq. 2.   
6.4.2 DASNYL Steady-state Emission Spectra 
The smoothed and normalized DANSYL steady-state emission spectra are 
plotted in Fig. 6.2 for all of the cholesterol concentrations used in this study at 
30°C (Fig. 6.2a) and 60°C (Fig. 6.2b).  In Fig. 6.3a the SCG, is plotted as a 
function of cholesterol concentration at both 30°C and 60°C in DMPC-cholesterol 
MLV.  The DANSYL steady-state spectral sensitivity to cholesterol in model 
lipid membranes is readily observed in Fig. 6.3a, as a dose-dependent blue shift in 
the SCG at 30°C.  At 30°C the DANSYL SCG is 514 nm at Xchol=0 and decreases 
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to 511 nm by Xchol=0.15.  The DANSYL SCG decreases approximately linearly 
from 507 nm at Xchol=0.20 to a value of 479 nm at Xchol=0.60.  Upon heating to 
60°C a complete alleviation of the blue shift is observed at low cholesterol 
loadings and a partial alleviation of the blue shift is observed at high cholesterol 
loadings by the systematic increase in the SCG as function of cholesterol loading.  
Specifically, at 60°C the DANSYL SCG remains at a constant value of 520 nm 
over the range Xchol=0 to Xchol=0.25, then decreases approximately linearly from 
520 nm at Xchol=0.30 to a value of 484 nm at Xchol=0.60.   
To determine if the addition of cholesterol induces a shape change in the 
DANSYL steady-state emission spectra, the SHW, as defined by Eq. 2 is 
calculated and plotted as a function of cholesterol mole fraction in Fig. 6.3b at 
30°C and 60°C.  At 30°C the SHW of the DANSYL spectra is approximately 
constant at a value of 47 nm at cholesterol mole fractions between Xchol=0 and 
Xchol=0.30 as a function of cholesterol concentration, at cholesterol concentrations 
higher the Xchol=0.30 the DANSYL spectra slightly narrows systematically to a 
value of 43 nm.  Upon heating to 60°C the DANYSL emission spectra widens to 
a values of 47 nm at high cholesterol loadings.  This narrowing of the spectra at 
high cholesterol loadings at 30°C and the subsequent widening upon heating to 
60°C is the first indication that specific effects may be occurring in the system.   
6.4.3 Steady-state Excitation Spectra 
The DANSYL probe has two absorption bands as seen in Fig. 6.2c and 
Fig. 6.2d.  The first band is centered at 340 nm, and the second band is centered at 
260 nm.  Fig. 6.3c shows the SCG of the 340 nm and 260 nm absorption bands as 
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a function of cholesterol loading at both 30°C and 60°C, while in Fig. 6.3d is 
plotted the SHW of the 340 nm and 260 nm absorption bands as a function of 
cholesterol loading at both 30°C and 60°C.  The lack of any spectral shifting or 
shape changes in the excitation spectra suggest that electronic polarization is not 
contributing to the observed cholesterol dose dependent DANSYL steady-state 
emission blue shifts.  Electron redistribution occurs on the absorption time scale 
and would be detectable by spectral changes in the absorption spectra as a 
function of cholesterol concentration and temperature.   
6.4.4 Time-resolved Emission Spectra Studies of DANSYL in DMPC-
Cholesterol MLV 
 
To explore the possibility that time-dependent solvent effects are 
contributing to the DANSYL steady-state cholesterol dose dependent blue shift 
we measured the DANSYL TRES for DMPC bilayer mixtures with increasing 
amounts of cholesterol, in 10 mol.% increments, in the range 0-60mol.% at 30C° 
and 60°C.  In Fig. 6.4a the DANSYL SCG is plotted as a function of time in 
DMPC-cholesterol MLV at 30°C.  The general trend in these data is the emission 
is initially blue, and shifts to longer wavelength (red shifted) emission at later 
times.  At 30°C the SCG at the moment of excitation (Fig. 6.4a, t=38 ns) are 487 
nm, 486 nm, 490 nm, 487 nm, 482 nm, 475 nm, and 470 nm for the 0, 0.10, 0.20, 
0.30, 0.40, 0.50, and 0.60 cholesterol mole fraction samples, respectively.  Fig. 
6.4a clearly shows that above a cholesterol mole fraction of 0.30 the DANYSL 
probe does not reach a relaxed state, the SCG is still increasing at 99 ns.  
Examples of un-relaxed (t=38 ns) and relaxed (t=79) ns DANSYL spectra are 
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plotted in Fig. 6.5 for the 0mol.% cholesterol sample at 30°C.  The intrinsic 
fluorescence decay time of the DANSYL probe is ~11 ns.  Thus even after 
approximately six times the intrinsic decay time, the spectral relaxation is 
incomplete at 30°C.   
Fig. 6.4b shows the DANSYL SCG as a function of delay time in DMPC-
cholesterol MLV at 60°C.  At 60°C the SCG at the moment of excitation (Fig. 
6.4b, t=38 ns) are 498 nm, 498 nm, 498 nm, 496 nm, 490 nm, 481 nm, and 474 
nm for the 0, 0.10, 0.20, 0.30, 0.40, 0.50, and 0.60 cholesterol mole fraction 
samples respectively.   
It is difficult to measure reliably the TRES at delay times greater than 60 
ns after the excitation because the signal to noise ratio is too low, especially at the 
lower cholesterol concentrations because DANSYL fluorescence intensity 
increases with increasing cholesterol concentrations [6].   
The rate of spectral relaxation is quantified by fitting the time course of the SCG 
as a function of time after the excitation pulse with Eq. 3.  The best fit parameters 
are then used to calculate the mean spectral relaxation time using Eq. 4.  The 
mean spectral relaxation time as a function of cholesterol loading at 30°C and 
60°C is plotted in Fig. 6.6.  At 30°C the mean spectral relaxation time increases 
from 3.07 ns at Xchol=0 to 3.50 ns at Xchol=0.20, then increases dramatically from 
4.24 ns at Xchol=0.30 to a value of 14.17 ns at Xchol=0.60.  Upon heating to 60°C 
the mean spectral relaxation time at Xchol=0 is 1.31 ns and increases slightly to a 
value of 1.95 ns at Xchol=0.30, then increases linearly to a value of 11.44 ns by 
Xchol=0.60.  The rate of solvent relaxation is governed by the mobility of the 
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molecules in the solvent shell surrounding the DANSYL probe, as well as the 
mobility of the DANSYL-labeled phospholipids within the membrane.   
To determine if the DANSYL TRES are undergoing a time-dependent 
shape change we calculated the SHW as function of time during the fluorescence 
decay.  Fig. 6.4c shows the DANSYL SHW as a function of time after the 
excitation pulse in DMPC-cholesterol MLV at 30°C.  At 30°C and low 
cholesterol loadings (Xchol< 0.30) the general behavior is that the spectra narrows 
rapidly and remains constant thereafter.  At intermediate and high cholesterol 
loadings (Xchol ≥ 0.30) there is a widening of the spectra at intermediate times (41 
ns to 59 ns) followed by a slight decrease at long times (t > 59 ns).  These data 
clearly reveal a time-dependent shape change, a behavior attributable to the 
presence of specific probe and solvent effects such as hydrogen bonding or the 
formation of internal charge transfer states [20].  This is evidence of at least two 
distinct excited state populations of DANSYL in DMPC-cholesterol MLV at 
cholesterol mole fractions between 0.30 and 0.60.  Fig. 6.4d shows the DANSYL 
SHW as a function of time after the excitation pulse in DMPC-cholesterol MLV at 
60°C.  Upon being heated from 30°C to 60°C the same trend in the time course of 
the SHW is observed, but the widening of the spectra at intermediate times occurs 
for Xchol ≥ 0.40 compared to Xchol ≥ 0.30 at 30°C.   
6.4.5 DANSYL Quenching Studies in DMPC-Cholesterol MLV 
The purpose of these quenching studies is to estimate the DANSYL 
penetration depth into the membrane, and to determine the ability of water to 
penetrate into the membrane.  To determine the effects of cholesterol and 
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temperature on the location of the DANSYL probe within the membrane we 
measured the DANSYL steady-state fluorescence emission spectra in DMPC-
cholesterol MLV in the presence of 5-DOXYL-PC and 16-DOXYL-PC as a 
function of cholesterol loading at 30°C and 60°C.  The amount of quenching is 
quantified by the quenching ratio, RQ, defined by Eq. 5.  The DANSYL 
membrane penetration depth is estimated by using the 5-DOXYL-PC and 16-
DOXYL-PC quenching ratio data to calculate Zcf, the probe distance from the 
center of the bilayer.  To approximate the ability of water to penetrate the 
membrane as a function of cholesterol loading we measured the DANSYL steady-
state fluorescence emission spectra in the presence of the aqueous quencher 
CoCl2.   
6.4.6 Aqueous Quenching with 10mM Co2+ 
Fig. 6.7a shows the quenching ratio, (RQ), calculated with Eq. 5, as a 
function of cholesterol loading at 30°C in DMPC-cholesterol MLV.  At Xchol=0 
RQ  is 0.72 and increases linearly with increases cholesterol loading to a value of 
1.02 (complete alleviation of quenching) at Xchol=0.30.  In the cholesterol 
concentration range of Xchol=0.35-0.60, RQ is approximately a constant value of 
0.93.  The systematic increase in RQ over the cholesterol mole fraction range 0 to 
0.30 suggests that the addition of cholesterol inhibits the ability of the aqueous 
Cobalt quencher to access the DANSYL probe in the bilayer, and the ability to 
quench is slightly restored at cholesterol mole fractions above 0.30.  In Fig. 6.7b 
the SCG as a function of cholesterol loading at 30°C is shown for the 10 mM 
CoCl2 (□) and the un-quenched (◊) DANSYL sample sets.  The 10 mM CoCl2 
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induces 1.5 nm blue shift at Xchol =0 and decreases with increased cholesterol 
loading to a value of 0.4 nm at Xchol=0.30.  At cholesterol mole fractions above 
0.30 10 mM CoCl2 does not induce a blue shift in the SCG.   
6.4.7 Site Specific DANSYL Quenching with 5-DOXYL-PC and 16-
DOXYL-PC 
 
Fig. 6.8 shows the quenching ratio as a function of cholesterol loading 
with 5-DOXYL-PC(◊) and 16-DOXYL-PC(□) at 30°C(Fig. 6.8a) and 60°C(Fig. 
6.8b).  For 5-DOXYL-PC at 30°C and Xchol=0 the quenching ratio is 0.50 and 
decreases approximately linearly with increased cholesterol loading to a value of 
0.25 at Xchol=0.20.  The quenching ratio remains at a constant value of 0.25 over 
the cholesterol concentration range Xchol=0.20 to Xchol=0.40.  At cholesterol 
concentrations above Xchol=0.40, RQ increases with increasing cholesterol 
concentration to a value of 0.63 at Xchol=0.60.  For 16-DOXYL-PC at 30°C the 
quenching ratio at Xchol=0 and is 0.69, and decreases with increasing cholesterol 
loading to a value of 0.53 at Xchol=0.20.  In the cholesterol concentration range 
Xchol=0.20 to Xchol=0.35 the quenching ratio is constant at a value of 0.54.  At 
Xchol=0.40 the quenching ratio is 0.40 and decreases with increasing cholesterol 
concentration to a value of 0.34 at Xchol=0.60.  At 60°C for 5-DOXYL-PC the 
quenching ratio decreases approximately linearly from a value of 0.45 at Xchol=0 
to a value of 0.33 at Xchol=0.60.  Upon being heated to 60°C the quenching ratio 
for 16-DOXYL-PC is 0.67 at Xchol=0 and slightly decreases with increasing 
cholesterol loading to a value of 0.58 at Xchol=0.20.  The quenching ratio remains 
at an approximately constant value of 0.61 over the cholesterol concentration 
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range of Xchol=0.20 to Xchol=0.45, and then decreases with increasing cholesterol 
loading to a value of 0.39 at Xchol=0.60.   
To determine if the DANSYL probe is existing at multiple depths we 
examine the steady-state spectral shifting induced by the 5-DOXYL-PC and 16-
DOXYL-PC relative to the unquenched SCG.  In Fig. 6.9 the SCG as a function of 
cholesterol concentration at both 30°C (Fig, 6.9a) and 60°C (Fig. 6.9b) is plotted 
for the 5-DOXYL-PC (□), 16-DOXYL-PC (∆), and the unquenched DANSYL (◊) 
sample sets.  The 5-DOXYL-PC induces a discernible blue shift from the 
unquenched DANSYL SCG at all cholesterol concentrations used in this study, 
while the 16-DOXYL-PC induces a red shift of similar magnitude in the SCG as 
compared to the unquenched DANSYL sample set at both 30°C and 60°C.  These 
spectral shifts induced by the 5-DOXYL-PC and the 16-DOXYL-PC suggest that 
the DANSYL probe is accessible to both the quenchers and may be residing at 
both shallow and deep locations within the bilayer over the cholesterol mole 
fraction range of 0 to 0.60.   
6.4.8 DANSYL Penetration Depth Estimation Using Parallax Analysis 
Fig.6.10 shows the distance from the center of the bilayer for the 
DANSYL probe in DMPC-cholesterol MLV as a function of cholesterol loading 
at 30°C (◊) and 60°C (□) calculated from the 5-DOXYL-PC (shallow) and 16-
DOXYL-PC (deep) quenching data using parallax analysis (Eq. 6) [22].  The 
distance of the shallow quencher to the center of the bilayer, Lc1 in Eq. 6, is set to 
12.15 Å, and the distance between the shallow and deep quenchers, L21 in Eq. 6, is 
set to 9 Å for the calculation of the DANSYL distance from the bilayer center, Zcf, 
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as a function of cholesterol loading [23].  At 30°C the calculated distance from 
the bilayer center is 11.7 Å at Xchol=0 and increases steadily to a value of 18.1 Å 
at Xchol=0.30.  At cholesterol concentrations beyond Xchol=0.30 and 30°C Zcf 
decreases sharply with increasing cholesterol loading to a value of 0.1 Å at 
Xchol=0.60.  At 60°C the DANSYL distance from the center of the bilayer at 
Xchol=0 is 12.5 Å and increases somewhat linearly with increased cholesterol 
loading to a value of 16.9 Å at Xchol=0.50.  At cholesterol mole fractions greater 
than 0.50 the Zcf decreases sharply with increased cholesterol loading to a value of 
7.7 Å by Xchol=0.60.  Given that the parallax analysis reports that the DANSYL 
probe resides at shallow depths within the membrane in the 0 to 0.30 cholesterol 
mole fraction range, the alleviation of quenching by CoCl2 in that range may be 
due to the cholesterol-induced condensation of the head group area and the 
consequent dehydration of the interface region, but is consistent with DANSYL 
existing at multiple depths within the bilayer.   
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6.5 Discussion 
In this work we preformed a steady-state and time-resolved emission 
spectra study of the fluorescent properties of the membrane probe DANSYL in 
DMPC MLV prepared by modified rapid solvent exchange as a function of 
cholesterol concentration at 30°C and 60°C.  We characterized both the steady-
state and TRES data by calculating the SCG and the SHW with Eq. 1 and Eq. 2 
respectively.  The rate of spectral relaxation was quantified by fitting the TRES 
SCG(t) data with Eq. 3 and calculating the mean spectral relaxation time with Eq. 
4.  We also performed fluorescence quenching studies utilizing CoCl2 as an 
aqueous quencher and 5-DOXYL-PC and 16-DOXYL-PC as site specific 
quenchers located at the fifth and sixteenth carbon along the phospholipid acyl-
chains.  The purpose of this investigation was to determine the molecular 
mechanism of the DANSYL steady-state fluorescence spectral sensitivity to 
cholesterol concentration, temperature, and phase behavior in model lipid 
membranes.   
6.5.1 DANSYL Steady-state Cholesterol Induced Blue Shifts are Caused by 
Time-dependent Solvent Effects and the Formation of ICT States 
 
Four factors determine the SCG of the steady-state emission spectra of 
DANSYL in DMPC-cholesterol MLV: 1) the energy of the un-relaxed state, 2) 
the energy of the relaxed state, 3) the rate of spectral relaxation, and 4) the 
formation of ICT states.  The energies of the un-relaxed and the relaxed state 
reflect the polarity of the local environment surrounding the DANSYL probe.  
The SCG data at the moment of excitation (t=38 ns, Fig. 6.4a and Fig. 6.4b) is the 
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most representative of the un-relaxed state.  From Fig. 6.4 we can see that the 
polarity of the local environment surrounding the DANSYL probe remains 
relatively constant over the cholesterol mole fraction range of Xchol=0 to 
Xchol=0.30 by the approximately constant value of the SCG at un-relaxed state at 
38 ns and only a 3 nm shift in the SCG at the relaxed state at 79 ns (which is 
consistent with a slight decrease in the local polarity), despite a liquid-disordered 
to liquid-ordered phase transition (the lo and ld phase boundaries are 
approximately Xchol=0.075 and Xchol=0.28 in DMPC MLV at 30°C) [24].  These 
results confirm that the DANSYL probe prefers the liquid disordered phase to the 
liquid ordered phase and is consistent with other reports that DANSYL prefers the 
fluid phase in 1,2-dipalmitoyl-sn-glycero-3-phosphocholine and 1,2-dilinoleoyl-
sn-glycero-3-phosphocholine lipid mixtures [14].  At Xchol > 0.30 the energies of 
the un-relaxed and relaxed states increases, which is consistent with a decrease in 
local polarity around the DANSYL probe at these cholesterol concentrations.   
The rate of spectral relaxation is governed by the mobility of the solvent 
molecules in the shell surrounding the DANSYL probe, and is also coupled to the 
mobility of the labeled macromolecule.  Therefore, diffusion limitations of the 
solvent and probe will affect the rate of spectral relaxation.  The rapid red shift in 
the SCG trajectories of the TRES data at low cholesterol concentrations (see Fig. 
6.4) is due to water reorganization around the DANSYL excited state. The mean 
relaxation times observed at high cholesterol concentrations are still due to the 
movement of water but also are representative of macromolecular and acyl-chain 
motions.  Solvent relaxation is an interaction between a polar fluorescent probe 
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and polar solvent molecules and therefore non-polar molecules do not directly 
contribute to the process.  Rather non-polar molecules, in this case the 
phospholipid acyl-chains and cholesterol act indirectly as diffusion barriers to 
water movement surrounding the DANSYL probe.  Our results show that water 
and DANSYL are still interacting at high cholesterol compositions in DMPC 
MLV.   
Analysis of the spectral shape as a function of time was used to determine 
whether the DANSYL spectral relaxation process is best described by the 
continuous model, or the two-state model, and to detect for the presence of ICT 
states [20].  At 30°C, we find that at low and intermediate cholesterol loadings 
(Xchol < 0.30) the relaxation process is best described by the continuous model, 
while at high cholesterol loadings (Xchol > 0.30), we observe evidence of two-state 
model behavior.  In all cases studied, however, the relaxation process in neither 
purely continuous nor purely two-state, but rather exhibits attributes of both 
models.  We interpret these data as follows: at low cholesterol loadings, most of 
the DANSYL probe is in a polar environment and forms ICT states.  The 
DANSYL probe has an electron accepting sulfonyl group and an electron 
donating amino group, and could allow for multiple conformations of ICT states.  
The presence of the water stabilizes the ICT states of the DANSYL probe.  The 
ICT states have lower energies than the native state, thus the emission is red 
shifted.  The distinct lack of spectral shifts in the steady-state absorption spectra is 
evidence that the specific interactions are only occurring in the excited state, and 
this points strongly towards the formation of ICT states over hydrogen bonding as 
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hydrogen bonding is expected to also occur in the ground state [4].  At cholesterol 
loadings of Xchol=0.30 and above the DANSYL probe exists in two distinct forms; 
an ICT state and a native state (non-ICT state).  The native state is in a non-polar 
environment, so that any ICT states formed are not stabilized and the resulting 
fluorescence emission is of higher energy (i.e. more blue).  These results lead us 
to suspect that the ICT state emission originates from DANSYL located at 
shallow depths in the membrane, and likewise the native state emission is from 
DANSYL located in the hydrophobic core.  The stabilization of the ICT state is 
very rapid (on the order of ~3 ns), while the spectral relaxation around the native 
state is slower (~10 to 15 ns).  When most of the DANSYL emission is from the 
native state, the slow rate of spectral relaxation dominates the steady-state 
emission spectra.   
6.5.2 The Depth of DANSYL Probe within the Membrane is Dependent on 
Cholesterol Concentration and Temperature and Membrane Phase 
Behavior 
 
To test our hypothesis that the DANSYL is located at shallow depths in 
the bilayer at low cholesterol concentrations and resides at deep locations at high 
cholesterol concentrations we performed fluorescence quenching studies to 
estimate the DANSYL location in the membrane as a function of cholesterol 
loading and temperature.  The results of the parallax analysis (See Fig. 6.10) show 
that the DANSYL membrane penetration depth is dependent on cholesterol 
concentration and temperature.  The initial rise in Zcf over the Xchol=0 to 
Xchol=0.30 is perhaps surprising because both the 5-DOXYL-PC, and the 16-
DOXYL-PC data suggest that DANSYL resides deeper within the membrane with 
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increased cholesterol loading over this composition range.  However, the parallax 
analysis used in this study does not take into account that the addition of 
cholesterol can increase the bilayer thickness by 10-15% [25].  The DANSYL 
probe might be at the same depth relative to the bilayer surface, but farther from 
the bilayer center, as a result of the cholesterol-driving condensation effect.  
Furthermore, the parallax analysis supports the hypothesis that heating causes the 
DANSYL probe to reorient closer to the bilayer surface by the increase in Zcf at 
Xchol > 0.30 upon heating to 60°C.  Our findings are consistent with other studies 
reporting that DANSYL-labeled phospholipids locate near the hydrophilic-
hydrophobic interface in pure 1,2-dioleoyl-sn-glycero-3-phosphocholine 
membranes [26,23].  Other researchers have reported that tail-labeled DANSYL 
phospholipids and other polar groups have also been shown to exist at multiple 
depths in pure 1,2-dioleoyl-sn-glycero-3-phosphocholine model membranes [14].  
Our most compelling evidence of DANSYL residing at both shallow and deep 
locations in DMPC-cholesterol bilayers comes from the spectral shifts induced by 
the 5-DOXYL-PC (induces blue shift) and 16-DOXYL-PC (induces red shift) at 
all cholesterol concentration used in this study (see Fig 6.9).  These data suggest 
that most of the DANSYL is residing at shallow depths in this low cholesterol 
region and that the high fluidity of the membrane allows for rapid solvent 
relaxation, even for DANSYL residing deep within the hydrophobic core.  
Although our DANSYL TRES analysis shows no evidence of two-state model 
behavior (i.e. two separate distinguishable DANSYL populations) for DMPC 
MLV below Xchol=0.30, the data in Fig. 6.9 demonstrates clearly that the 
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DANYSL is accessible to both the 5-DOXYL-PC and the 16-DOXYL-PC.  
Alternatively, at low cholesterol concentrations, the DANSYL is able to move up 
and down within the bilayer dynamically on a time scale comparable to the 
intrinsic decay time of ~11 ns and interact with both the shallow and deep 
quenchers.  The results of study support the existence of laterally phase separated 
cholesterol rich domains in DPMC MLV at cholesterol concentrations above 
Xchol=0.30 in DMPC MLV. 
Our results presented in this work and our previous study (Troup et al., 
2003) are more consistent with the condensed cholesterol complex [27] and 
superlattice [28] models of the lateral distribution of cholesterol and phospholipid 
within the membrane then the umbrella model [17].  While we suspect these 
laterally phase separated cholesterol rich domains are an equilibrium phase it is 
possible that they represent a dynamic phase that has a lifetime of a least on the 
order of 10 ns to be detectable by DANSYL. 
6.6 Summary 
The key findings of this investigation are: 1) the identification of two-state 
model behavior in the DANSYL TRES data for DMPC-cholesterol mixtures with 
cholesterol mole fractions above 0.30, and 2) the DANSYL membrane 
penetration depth is dependent on cholesterol concentration and temperature.  The 
first finding is important because the analysis of TRES data confirms that two 
separate populations of DANSYL are in coexistence with each other, and supports 
the existence of laterally phase separated cholesterol-rich domains in DMPC 
MLV at cholesterol concentrations above the lo and ld phase coexistence region.  
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The first DANSYL population is in a polar environment and the fluorescence 
emission is from ICT states.  The second DANSYL population is in a non-polar 
environment and cannot form ICT states and the resulting fluorescence emission 
is from the native state (non-ICT state).  The results of the DANSYL quenching 
studies support the findings of the TRES studies by showing that the DANSYL 
resides at shallow depths at low cholesterol loadings and penetrates deeper into 
the membrane at higher cholesterol loadings. 
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Figure 6.1 The chemical structure of the DANSYL and n-DOXYL-PC 
probes.  (a) DANSYL, (b) 5-DOXYL-PC, (c) 16-DOXYL-PC. 
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Figure 6.2 Steady-state fluorescence spectra of DANYL in DMPC-cholesterol 
MLV.  (a) steady state emission spectra as a function of cholesterol loading at 
30°C, (b) steady state emission spectra as a function of cholesterol loading at 
60°C.  (c) steady state excitation spectra as a function of cholesterol loading at 
30°C, (d) steady state excitation spectra as a function of cholesterol loading at 
60°C.   
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Figure 6.3 Steady-state fluorescence spectral characterization of DANYL in 
DMPC-cholesterol MLV.  (a) Spectral center of gravity of the steady state 
emission spectra as a function of cholesterol loading, (◊) 30°C, (□) 60°C.  (b) 
Spectral half width of the steady state emission spectra as a function of 
cholesterol loading, (◊) 30°C, (□) 60°C.  (c) Spectral center of gravity of the 
steady state excitation spectra as a function of cholesterol loading, (◊) 30°C 550 
nm, (□) 60°C 550 nm, (∆) 30°C 450 nm, (×) 60°C 450 nm.  (d) Spectral half 
width of the steady state excitation spectra as a function of cholesterol loading, (◊) 
30°C 550 nm, (□) 60°C 550 nm, (∆) 30°C 450 nm, (×) 60°C 450 nm.  
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Figure 6.4 Time resolved emission spectral characterization of DANSYL-
DMPC as a function of cholesterol loading and temperature.  DANSYL spectral 
center of gravity as a function of time at (a) 30°C, (b) 60°.  DANSYL spectral 
half width as a function of time at (c) 30°C, (d) 60°.  (◊) Xchol=0, (□) Xchol=0.10, 
(∆) Xchol=0.20, (×) Xchol=0.30, (∗) Xchol=0.40, (○) Xchol=0.50, (+) Xchol=0.60.  
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Figure 6.5 Characteristic relaxed and un-relaxed DANSYL spectra. DANSYL 
Time resolved emission spectra in 0mol.% cholesterol DMPC MLV at 30°C for 
delay times of 38 ns and 79 ns.  The TRES at 38 ns is representative of the un-
relaxed spectra and the TRES at 79 ns is representative of the relaxed spectra.  
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Figure 6.6 Mean spectral relaxation time as a function of cholesterol loading 
and temperature.  Calculated from Eq. 4, from the best-fit parameters from fitting 
the apparent TRES spectral center of gravity data with Eq. 3, (◊) 30°C, (□) 60°C.   
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Figure 6.7 Cholesterol alleviates DANSYL quenching by 10 mM aqueous 
CoCl2.  (a) DANSYL quenching ratio (RQ) as a function of cholesterol loading 
using 10 mM Co2+ as an aqueous quencher, (◊) 30°C, (b) DANSYL SCG as a 
function of cholesterol loading in DMPC MLV at 30°C, (◊) no quencher, (□) 10 
mM CoCl2.   
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Figure 6.8 DANSYL site specific quenching data. DANSYL quenching ratio 
as a function of cholesterol loading in DMPC-cholesterol MLV using the site-
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specific quencher (◊) 5-DOXYL-PC, and 16-DOXYL-PC (□), at 30°C(a) and 
60°C(b).   
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Figure 6.9 Evidence of the DANSYL probe residing at multiple depths in 
DMPC-cholesterol MLV.  The spectral center o f gravity (SCG) is plotted as a 
function of cholesterol mole fraction in DMPC-cholesterol MLV at 30°C(a) and 
60°C(b), (◊) no quencher, (□) 5-DOXYL-PC, (∆) 16-DOXYL-PC.  The 5-
DOXYL-PC induces a blue shift in the SCG as a function of cholesterol loading, 
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while the 16-DOXYL-PC induces a red shift in the SCG as a function of 
cholesterol loading.   
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Figure 6.10 DANSYL resides at deep locations within the bilayer at 30°C and 
shallow locations in the bilayer at 60°C at high cholesterol loadings.  Zcf, the 
DANSYL distance from the center of the bilayer as a function of cholesterol 
loading using parallax analysis in DMPC-cholesterol MLV at (◊) 30°C, (□) 60°C.  
The increase in Zcf at low cholesterol loadings is due to the addition of cholesterol 
increasing the bilayer thickness and the sharp decrease of Zcf at high cholesterol 
loadings demonstrates that the DANSYL is residing deeper in the membrane at 
30°C.  Upon heating to 60°C the DANSYL locates at shallow depths in the 
membrane at high cholesterol concentrations.   
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CHAPTER 7: Recommendations 
 
7.1 Introduction 
The overall goals of this work as outlined in chapter 3 were to develop 
fluorescence techniques to detect and estimate the size of laterally phase separated 
cholesterol domains in model membrane systems, and to determine the molecular 
mechanism of the DANSYL steady state spectral sensitivity to cholesterol and 
membrane phase behavior.  While those goals were largely met in this work, in 
this section I will describe my recommendations for future studies involving 
laterally phase-separated cholesterol domains in model membranes.   
7.2 DANSYL Studies in Biological Colloids 
Now that we have a deeper understanding of how tail-labeled DANSYL 
probes behave in model membranes that contain cholesterol, we can use it to 
study other colloidal particles that contain cholesterol such as lecithin and 
cholesterol bile salt mixed micelles and lipoprotein type colloidal particles.  Any 
future studies that include DANSYL will require nitroxide quenching studies to 
determine the location of the DANSYL probe within the system under all 
experimental conditions.  Also quenching studies with an aqueous quencher will 
be useful in determining the water access to the DANSYL.  This cannot be 
stressed enough, as shown in chapter 6 the DANYSL photo physics are highly 
complex.   
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7.3 FRET Studies 
The DANSYL was shown to somewhat unsuitable as an energy transfer 
acceptor because of the time dependent solvent effects overlapping with the donor 
emission, thus making time-resolved FRET analysis too complicated for practical 
application.  Another FRET acceptor for ERGO needs to be identified that has 
constant spectral properties in colloidal particles.  This will allow time-resolved 
FRET studies to be preformed that will offer additional information that steady 
state FRET studies can not provide.  This will also lend it self to using the FRET 
simulations described in chapter 5 to test the effects of lateral phase separation 
(preferential probe segregation) on the recovered parameters from the FRET 
decay models outlined in chapter 2.  The simulated decays generated from the 
probe distributions in the membrane lattice model can have Poisson noise added 
to them, and then be convoluted with an experimental lamp pulse.  The simulated 
measured response functions can then be analyzed with the simplified FRET 
models described in chapter 2 to extract the model parameters.  Comparisons can 
then be made with the extracted decay parameters from experimental decays 
parameters.  The FRET simulations described in chapter 5 can be used to study 
FRET in colloidal particles with geometries other than bilayer, for example: rod-
like micelles or lipoprotein like particles. 
7.4 Visualization of Cholesterol Domains: AFM Studies 
Visualization will be the ultimate evidence for the existence of the 
laterally phase-separated domains in model membranes.  Atomic Force 
microscopy offers some interesting possibilities in the study of cholesterol 
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nucleation as well as in domain formation.  The first phase of these future studies 
includes imaging of DMPC supported bilayers as a function of cholesterol loading 
to detect the presence of cholesterol-rich laterally phase separated domains and to 
characterize their properties (size and number) as a function of increasing 
cholesterol loading.  The second phase is to use the supported membrane model 
system to study the effect of the pro-nucleating agents such as bile salts on the 
morphology of the supported bilayers by AFM visualization.  AFM technology 
can allow the effects of pro-nucleating agents on supported membrane bilayers to 
be visualized in real time, or at least as fast as the AFM can scan the sample area.  
Bile salt micelles are known to supersaturate cholesterol bilary phospholipid 
vesicles by preferentially removing phospholipid to form mixed micelles, and 
thus leaving the resultant membrane fragments enriched in cholesterol.  This 
action of the pro nucleating bile salts will induce cholesterol nucleation.  By 
imaging the supported membrane bilayers before and after bile salt treatment the 
effect of cholesterol super-saturation on the membrane morphology can be 
viewed.   
Supported membrane bilayers will be prepared by the method of vesicle 
fusion.  Briefly, 75 micro-liters of the SUV in aqueous buffer solution pH=7.3 
will be pipetted onto freshly cleaved mica surfaces.  Then the samples will be 
heated to 60 degree C for one hour, and then allowed to cool to room temperature.  
The excess SUV and MLV will be rinsed off with buffer solution leaving a 
supported membrane bilayer.  If fluid phase lipids cannot be supported, we will 
use DPPC instead of DMPC.  Supported membrane bilayers will be prepared as 
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described above and AFM imaging will be preformed as a function of cholesterol 
concentration ranging from 30mole% cholesterol to 65mole%cholesterol.  
Cholesterol immiscible domains will be detected by the differences in the bilayers 
thickness of the laterally phase separated regions.  A tail-to-tail cholesterol bilayer 
domain will be about 3.5 nanometers thick, while the bilayer thickness in the 
continuous phase is expected to be about 5.0 nanometers thick.  A 1.5 nanometer 
thickness is in the detectable range of AFM resolution.   
7.5 Small Angle X-Ray Diffraction Studies to Determine Phase Diagram 
To determine the temperature and composition range over which 
cholesterol domains exist in model lipid membranes a rigorous small angle X-Ray 
study should be performed.  The suggested studies would include the preparation 
of cholesterol containing DMPC multi lamellar vesicles in one mole percent 
cholesterol intervals over the 0-66mol.% cholesterol range.  The studies should 
initially be conducted at 37°C and then be extended to a wider temperature range.  
The phase diagram generated from these studies can than be compared with the 
DANSYL results reported in chapter 4 and chapter 6 and the recommended AFM 
studies described above.  The indication that cholesterol domains are present is a 
d-spacing of 34 Å which is the tail-to-tail length of a cholesterol bilayer spanning 
domain.  DMPC-cholesterol MLV will be prepared by the method of modified 
rapid solvent exchange as described in chapter 2.   
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Figure 7.1 Illustration of AFM height analysis of immiscible cholesterol 
domains in a supported bilayer.   
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